
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            I‑GAT: Interpretable Graph Attention Networks for Ligand Optimization - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE475F89B71A531B475F00435535CD.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="acsomega">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="ACS Omega">
<meta name="citation_title" content="I‑GAT: Interpretable Graph Attention Networks for Ligand Optimization">
<meta name="citation_author" content="Ezek Mathew">
<meta name="citation_author_institution" content="Department of Microbiology and Immunology, The University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas 76107, United States">
<meta name="citation_author" content="Kyle A Emmitte">
<meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, University of North Texas System College of Pharmacy, The University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas 76107, United States">
<meta name="citation_author" content="Jin Liu">
<meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, University of North Texas System College of Pharmacy, The University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas 76107, United States">
<meta name="citation_publication_date" content="2025 Jul 21">
<meta name="citation_volume" content="10">
<meta name="citation_issue" content="30">
<meta name="citation_firstpage" content="32968">
<meta name="citation_doi" content="10.1021/acsomega.5c02173">
<meta name="citation_pmid" content="40787347">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/pdf/ao5c02173.pdf">
<meta name="description" content="Designing selective and potent ligands for target receptors remains a significant challenge in drug discovery. Computational approaches, particularly advancements in machine learning (ML), offer transformative potential in addressing this challenge. ...">
<meta name="og:title" content="I‑GAT: Interpretable Graph Attention Networks for Ligand Optimization">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Designing selective and potent ligands for target receptors remains a significant challenge in drug discovery. Computational approaches, particularly advancements in machine learning (ML), offer transformative potential in addressing this challenge. ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332587">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1021/acsomega.5c02173"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ao5c02173.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332587%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332587/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332587/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-acsomega.png" alt="ACS Omega logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to ACS Omega" title="Link to ACS Omega" shape="default" href="https://pubs.acs.org/journal/acsodf" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">ACS Omega</button></div>. 2025 Jul 21;10(30):32968–32986. doi: <a href="https://doi.org/10.1021/acsomega.5c02173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1021/acsomega.5c02173</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22ACS%20Omega%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22ACS%20Omega%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22ACS%20Omega%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>I‑GAT: Interpretable
Graph Attention Networks
for Ligand Optimization</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mathew%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ezek Mathew</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ezek Mathew</span></h3>
<div class="p">
<sup>†</sup>
Department
of Microbiology and Immunology, The University
of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort
Worth, Texas
76107, United States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mathew%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Ezek Mathew</span></a>
</div>
</div>
<sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Emmitte%20KA%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Kyle A Emmitte</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Kyle A Emmitte</span></h3>
<div class="p">
<sup>‡</sup>
Department
of Pharmaceutical Sciences, University of North Texas System College
of Pharmacy, The University of North Texas
Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas
76107, United
States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Emmitte%20KA%22%5BAuthor%5D" class="usa-link"><span class="name western">Kyle A Emmitte</span></a>
</div>
</div>
<sup>‡</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Jin Liu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Jin Liu</span></h3>
<div class="p">
<sup>‡</sup>
Department
of Pharmaceutical Sciences, University of North Texas System College
of Pharmacy, The University of North Texas
Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas
76107, United
States
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jin Liu</span></a>
</div>
</div>
<sup>‡,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>†</sup>
Department
of Microbiology and Immunology, The University
of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort
Worth, Texas
76107, United States
</div>
<div id="aff2">
<sup>‡</sup>
Department
of Pharmaceutical Sciences, University of North Texas System College
of Pharmacy, The University of North Texas
Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas
76107, United
States
</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>*</sup><p class="display-inline">
Email: <span>jin.liu@unthsc.edu</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 7; Accepted 2025 Jul 15; Revised 2025 Jul 10; Collection date 2025 Aug 5.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Authors. Published by American Chemical Society</div>
<p>This article is licensed under CC-BY-NC-ND 4.0</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332587  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40787347/" class="usa-link">40787347</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Designing selective and potent ligands for target receptors
remains
a significant challenge in drug discovery. Computational approaches,
particularly advancements in machine learning (ML), offer transformative
potential in addressing this challenge. In this study, our goal was
to develop a composite ML model capable of predicting ligand selectivity
and potency with high accuracy while also providing interpretable
insights to guide ligand optimization. To achieve this goal, we first
compiled a data set of 757 ligands, including metabotropic glutamate
receptor subtype 2 (mGlu2) negative allosteric modulators (NAMs),
metabotropic glutamate receptor subtype 3 (mGlu3) NAMs, and nonselective
dual mGlu2/3 NAMs from patent filings. In three phases, we developed
an ML model with Interpretable Graph Attention (I-GAT) networks for
drug optimization. In phase 1, we created a composite model that can
accurately predict selectivity and potency metrics by integrating
graph architecture with transfer learning methodologies. Our model
demonstrated over 97% accuracy in predicting ligand NAM selectivity
and upward of 78% accuracy in potency prediction. Phase 2 used attention
mechanisms to enhance model interpretability, effectively illuminating
the “black box” of ML decision-making. Finally, in phase
3, we utilized attention gradients to intelligently modify known ligands,
leading to the design of a novel ligand with predicted superior properties
compared to the original. Our approach demonstrates the dual benefits
of predictive accuracy and atom-level interpretability, offering a
powerful framework for ligand design. When applied to external data,
our model matched and, in some cases, exceeded the performance of
current state-of-the-art chemistry-focused ML models across multiple
data sets. Ultimately, our model has the potential to be adapted to
other receptors and molecular properties, paving the way for a more
efficient and targeted drug discovery process.</p></section><section class="abstract" id="abstract2"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/bc4b2672a158/ao5c02173_0016.jpg" loading="lazy" id="abs1" height="301" width="644" alt="graphic file with name ao5c02173_0016.jpg"></p></section><section class="abstract" id="abstract3"><hr class="headless">
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/bc4b2672a158/ao5c02173_0014.jpg" loading="lazy" id="tgr1" height="301" width="644" alt="graphic file with name ao5c02173_0014.jpg"></p></section><section id="sec1"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Selectivity and potency
are critical factors in the drug discovery
process. Designing ligands that effectively bind to specific target
receptors without affecting others is essential for therapeutic efficacy
and safety. However, this task is particularly challenging when there
is a high structural similarity between the receptors. Selectivity
is especially critical for G-protein-coupled receptors (GPCRs), the
largest family of signal transduction proteins,<em>
−


</em> due to their similar structures.
Considering that over 30% of Food and Drug Administration (FDA)-approved
drugs target exert biological activity through GPCR targeting, selectivity
considerations have widespread scientific and clinical implications.<em>
,
</em> Multiple factors, ranging from the surrounding water networks to
differences in binding poses, affect a ligand’s selectivity
for GPCRs. While the rules for ligand selectivity can be determined
on a case-by-case basis,<em>
,,
</em> conventional approaches face limitations when dealing with a large
number of candidate ligands. Additionally, in cases where sparser
quantities of ligands are available, conserved rules for optimizing
target properties may not be visible with manual analysis. These challenges
highlight the need for alternative methods that can systematically
assess selectivity, paving the way for more efficient and effective
drug discovery processes.</p>
<p>This need for improved selectivity
assessment is especially relevant
in the context of GPCRs, where closely related subtypes play divergent
roles but remain difficult to differentiate using conventional ligand
design. Among the GPCR family, metabotropic glutamate receptor subtype
2 (mGlu2) and metabotropic glutamate receptor subtype 3 (mGlu3) are
promising targets for neurological diseases. In general, mGlu2 activation
contributes to neuronal toxicity. Its genetic deletion can improve
outcomes after toxic insults.<em>
,
</em> On the other hand,
mGlu3 activation played a neuroprotective role, encouraging antiamyloidogenic
functions within astrocytes, which was evidenced through in vivo and
in vitro studies in the context of Alzheimer’s disease.<em>
,−

</em> Interestingly, simultaneous activation of mGlu2 and
mGlu3 signal transduction can be neuroprotective.<em>
,
</em> Considering the different functions that these receptors modulate,
the identification of selective ligands for either the mGlu2 or mGlu3
receptor could be beneficial in the treatment of various neurological
conditions.</p>
<p>The orthosteric binding pockets are highly conserved
between the
mGlu2 and mGlu3 receptors, making the design of selective ligands
specific to the orthosteric site extremely challenging.<em>
,
</em> Indeed, the structural similarity of mGlu2 and mGlu3 extends to
functional similarity, as studies have shown that identical mutations
in the binding sites of these receptors lead to analogous effects
on receptor function upon metabotropic group II ligand binding. These traits create difficulty when designing
receptor-specific ligands, for researchers who want to design ligands
that cater to the specific attributes of mGlu2 or mGlu3 signal transduction.
However, both mGlu2 and mGlu3 receptors possess distinct allosteric
sites in addition to their orthosteric sites. This distinction has
enabled the design of negative allosteric modulators (NAMs) that are
selective for either mGlu2 or mGlu3, representing an improvement over
the previously nonselective dual mGlu2/3 NAMs.<em>
−




</em> Therefore, drug design targeting differences in the mGlu2 and mGlu3
allosteric sites has facilitated advancements in this GPCR family
by enabling the selective modulation of two receptors with distinct
physiological roles. Despite recent advances in ligand development,
the existing library of compounds remains limited. At this time, there
are no efficient, scalable methods that can allow researchers to screen
large volumes of mGlu2 or mGlu3 candidate ligands for both potency
and selectivity. This gap underscores the need for computational approaches
to perform this task with greater precision, at scale. To address
this challenge, we sought to leverage advances in machine learning
(ML) and artificial intelligence (AI).</p>
<p>One promising direction
lies in the use of Graph Neural Networks
(GNNs), a class of deep learning architectures that has rapidly gained
traction since their introduction in 2005. Derivatives of this architecture
have been implemented to process a wide range of biological stimuli,
ranging from brain networks and medical images to medical text.<em>
−



</em> Due to their capacity to represent connectivity, GNNs may more natively
represent molecules through the perspective of chemistry, when compared
to other ML representations. Conversely, GNN-based models often require
more training time than descriptor-based models, dispelling the thought
that GNN implementation is a “silver bullet” for biological
tasks. However, the recent development
of certain GNN architectures, such as Graph Attention Networks (GATs),
often exceeded descriptor-based model performance, suggesting the
promising application of GNN in the field of drug discovery with task-specific
implementation and optimal architecture.
</p>
<p>The adaptation of GNNs to chemistry represents a natural progression
of this subfamily of ML architecture, supported by the abundance of
successful GNN applications in chemistry. Like other ML architectures,
graph-based models can be used for classification and regression.
For instance, GNNs have been used to predict toxicity profiles across
a variety of data sets.<em>
,
</em> They can also be used
to accurately predict molecular properties, serving as prime candidates
for use in regression tasks such as the prediction of water solubility,
hydration free energy in water, lipophilicity, and glass-transition
temperature.<em>
−

</em> Additionally, GNNs can be combined with other architectures,
like Convolutional Neural Networks (CNNs) to predict complex phenomena
such as compound–protein interactions. Ultimately, the application of GNNs to chemistry is a promising
scientific subfield, especially when considering the unique qualities,
such as interpretability.</p>
<p>As interest in interpretability grows,
several models within the
GNN subfamily have recently been developed. For example, GNNExplainer
leverages neighborhood aggregation to identify important graph features. Another methodology seeks to pair Graph Convolutional
Network (GCN) architecture with established methods of evaluating
feature salience, such as Local Interpretable Model-Agnostic Explanations
(LIME), Gradient-Based Saliency Maps, and Gradient-Weighted Class
Activation Mapping (Grad-CAM). Although
these methods were originally suited to CNN architectures, the authors
indicate that their approach can apply to convolutions with graph
data.
</p>
<p>Most currently available
ML models seek to evaluate the importance
of certain atoms on target properties but encounter multiple limitations,
including a lack of atomic-level resolution and reliable interpretability.
For example, a GNN model used Grad-CAM to correlate atomic structure
to X-ray absorption spectra. However, only four node features could
be incorporated, and the approach had to work within the limitations
of Grad-CAM integration. An interpretable
GCN derivative sought to evaluate the structural contribution to chromatographic
retention using saliency maps; however, interpretability was limited
to substructure-level resolution. Structural
relation to activity was elucidated with another GCN model, which
assessed the defined substructures without atomic-level resolution. A similar lack of atomic level resolution limitation
is encountered in another work corroborating substructure importance
for graph architecture. Another approach
used Shapley approximation with the Monte Carlo sampling; however,
the approach demonstrated inconsistency between runs. There are also indirect methods for attaining interpretability.
For example, substructure masking can be used to identify the most
important substructures to a particular prediction, only affording
substructure-level resolution. In summary,
most of these prior models do not offer atomic-level resolution. They
work with various types of GCNs with older GNN architectures. Few
leverage GAT architecture for interpretable models. In this work,
we sought to build a GAT model while offering attention-based interpretability
methods to deliver atomic-resolution explanations, a feature rarely
seen in molecular GNNs.</p>
<p>Our study has three phases. In phase
1, we developed a multifunctional
prediction GAT model with three tasks. The first task aimed to accurately
predict selectivity, as a classification problem. The second task
functioned to predict potency (IC50) values, which was a regression
output. The third task also predicted potency but classified each
ligand as “high” or “low” potency. In
phase 2, we further developed the multifunctional model by integrating
interpretability, allowing us to examine ligands to identify strengths
and weaknesses. In phase 3, we leveraged this interpretable model
for drug optimization. This approach allowed for the design of a novel
ligand with enhanced mGlu2 NAM selectivity and improved potency, as
evaluated by computational methods. To assess the broader applicability
of our framework, we conducted comprehensive comparisons against state-of-the-art
machine learning models across multiple benchmark data sets. We were
able to adapt our model to various data sets with different features,
and we anticipate that future researchers will be able to build upon
this approach for their particular data sets. An overview of this
study is depicted in <a href="#fig1" class="usa-link">Figure 
</a>.</p>
<figure class="fig xbox font-sm" id="fig1"><h3 class="obj_head">1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/5e2c1cc58643/ao5c02173_0001.jpg" loading="lazy" id="gr1" height="588" width="599" alt="1"></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>General overview of three phases of this study. Phase 1 focused
on training the model to accurately predict ligand properties, including
selectivity and potency. After the model was successfully trained,
it was interrogated during phase 2 to identify the atoms or functional
groups that negatively affect selectivity/potency. Subsequently, in
phase 3, these regions were modified to optimize the ligand. The new
ligand was evaluated to determine if the modifications improved the
selectivity and/or potency of the ligand.</p></figcaption></figure></section><section id="sec2"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">2.1. Node Feature Selection</h3>
<p>To layer information
about chemical structures, a specialized encoding scheme was adopted
and node features were layered as inputs into graph architecture.
To tailor inputs to GNN adaptation, most input features were one-hot
encoded, which converts categorical data into a numerical vector where
each category is represented by a “1” (indicating the
presence of the category) and 0’s elsewhere. One-hot encoding
allows for ease of computation for aggregation functions that are
typical of GNN architectures, as features are represented in a fashion
that is favorable to mathematical operations. Of note, this encoding
can be paired with scaled vector values, allowing for the transmission
of categorical values, which can then be paired with other vector
values. For each constituent atom, information about atomic identity
was encoded, from the list of {Carbon (C), Nitrogen (N), Oxygen (O),
Phosphorus (P), Sulfur (S), Fluorine (F), Chlorine (Cl), Bromine (Br),
and Iodine (I)}. The scaled atomic weight, the total number of hydrogens
bound to a target atom, implicit and explicit valence were also included.
Covalent radius, van der Waals radius, formal charge, and partial
charges were calculated and appended as node features. Finally, degree,
aromaticity, and hybridization were also encoded as features. Ultimately,
the encoding of the aforementioned molecular attributes allowed for
the stacking of 54 node features, which were used to create a distinct
data object for each input ligand. More information about the rationale
for these features is hosted in the discussion section.</p></section><section id="sec2.2"><h3 class="pmc_sec_title">2.2. Data Set Creation</h3>
<p>As a list of mGlu2
and/or mGlu3 NAMs, along with the Simplified Molecular Input Line
Entry System (SMILES), is unavailable, we sought to generate this
data for ML applications. The two targets designated for selectivity
classification were mGlu2 or mGlu3, meaning that an input ligand could
be deemed as displaying selectivity as a NAM for one receptor. Thus,
data was compiled from a Merck patent and five Vanderbilt patents
to generate a data set of 351 mGlu2 NAMs and 309 mGlu3 NAMs.<em>
−




</em> As potency values were available for this data, the IC50 value distribution
of the data set is visualized in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S1</a>. All IC50 values were then transformed using a log base 10 (log10)
scale and subsequently normalized within their respective classes
(mGlu2 or mGlu3) based on their class-specific minimum and maximum
values.</p>
<p>One additional consideration was that the algorithm
may encounter ligands that function as NAMs while displaying nonselectivity
for mGlu2 and mGlu3 receptors at the allosteric site. Therefore, these
dual mGlu2/3 NAMs must be considered, and patents were referenced
for this purpose. Unfortunately, as some patents report differing
methodologies and measurements, they could not be included. However,
there was one particular patent that was included, US10597367B2. EC50 value reporting was incomplete in some
cases; many samples used varying or missing time points for the assays,
precluding a head-to-head comparison. Due to the lack of data, we
eliminated samples with missing data points. Additionally, some values
were out of the measured range, eliminating the possibility of including
potency metrics. After these samples were excluded, selectivity could
be extracted from the remaining 97 compounds. Compounds that demonstrated
a 10-fold potency difference for one receptor versus the other were
considered “selective”. This led to the addition of
13 mGlu2 selective NAM compounds and 1 mGlu3 selective NAM compound.
Compounds that did not achieve this cutoff were considered “non-selective”
and labeled as nonselective dual mGlu2/3 NAMs (<em>n</em> =
83). With all patents combined, the final count amounted to 364 mGlu2
NAMs, 310 mGlu3 NAMs, and 83 dual mGlu2/3 NAMs. The compiled data
set of 757 samples will be available in the supplementary section
within <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S13</a>.</p></section><section id="sec2.3"><h3 class="pmc_sec_title">2.3. Data Fractioning</h3>
<p>An independent validation
set was created using 10% of the data designated for testing, with
85% for training and 5% for model validation. A second set was created
after excluding 10% of the data designated for testing, for the purpose
of performing cross-validation. The StratifiedKFold module from scikit-learn
was used to split this data into 75% training, 5% validation, and
20% testing over five folds. This ensured randomization while allowing
future researchers to replicate this work.</p>
<p>The cross-validation
process is specifically included to assess the model’s robustness
and provides a reliable measure of performance across multiple runs.
In contrast, the independent test set is reserved for final model
evaluation, ensuring an unbiased assessment of generalization. Importantly,
the test set was never used during training or cross-validation, which
prevents the risk of data leakage during performance quantification.</p></section><section id="sec2.4"><h3 class="pmc_sec_title">2.4. Loss Functions</h3>
<p>For all classification
tasks, the loss function was BCEWithLogitsLoss, as detailed in <a href="#eq1" class="usa-link">eq 
</a>.</p>
<table class="disp-formula p" id="eq1"><tr>
<td class="formula"><math id="d1e350" display="block"><mrow><mi mathvariant="normal">BCEWithLogitsLoss</mi><mo>=</mo><mo form="prefix">−</mo><mfrac><mrow><mn>1</mn></mrow><mrow><mi mathvariant="italic">n</mi></mrow></mfrac><munderover><mrow><mo>∑</mo></mrow><mrow><mi mathvariant="italic">i</mi><mo>=</mo><mn>1</mn></mrow><mrow><mi mathvariant="italic">n</mi></mrow></munderover><msub><mrow><mi mathvariant="italic">y</mi></mrow><mrow><mi mathvariant="italic">i</mi></mrow></msub><mo>·</mo><mi mathvariant="normal">log</mi><mrow><mo stretchy="false">(</mo><mi>σ</mi><mrow><mo stretchy="false">(</mo><msub><mrow><mi mathvariant="italic">x</mi></mrow><mrow><mi mathvariant="italic">i</mi></mrow></msub><mo stretchy="false">)</mo></mrow><mo stretchy="false">)</mo></mrow><mo>+</mo><mrow><mo stretchy="false">(</mo><mn>1</mn><mo>−</mo><msub><mrow><mi mathvariant="italic">y</mi></mrow><mrow><mi mathvariant="italic">i</mi></mrow></msub><mo stretchy="false">)</mo></mrow><mo>·</mo><mi mathvariant="normal">log</mi><mrow><mo stretchy="false">(</mo><mn>1</mn><mo>−</mo><mi>σ</mi><mrow><mo stretchy="false">(</mo><msub><mrow><mi mathvariant="italic">x</mi></mrow><mrow><mi mathvariant="italic">i</mi></mrow></msub><mo stretchy="false">)</mo></mrow><mo stretchy="false">)</mo></mrow></mrow></math></td>
<td class="label">1</td>
</tr></table>
<p>For the regression task, Root Mean
Squared Error (RMSE) was used, with a slight modification detailed
in <a href="#eq2" class="usa-link">eq 
</a>.</p>
<table class="disp-formula p" id="eq2"><tr>
<td class="formula"><math id="d1e451" display="block"><mrow><mi mathvariant="normal">Modified RMSE loss</mi><mo>=</mo><msqrt><mfrac><mrow><munderover><mrow><mo>∑</mo></mrow><mrow><mrow><mi mathvariant="italic">i</mi></mrow><mrow><mo>=</mo></mrow><mrow><mn>1</mn></mrow></mrow><mrow><mi mathvariant="italic">n</mi></mrow></munderover><msup><mrow><mrow><mo stretchy="false">(</mo><mrow><msub><mrow><mi mathvariant="italic">y</mi></mrow><mrow><mi mathvariant="normal">true</mi></mrow></msub></mrow><mrow><mo>−</mo></mrow><mrow><msub><mrow><mi mathvariant="italic">y</mi></mrow><mrow><mi mathvariant="normal">pred</mi></mrow></msub></mrow><mo stretchy="false">)</mo></mrow></mrow><mrow><mn>2</mn></mrow></msup></mrow><mrow><msub><mrow><mi mathvariant="italic">y</mi></mrow><mrow><mi mathvariant="normal">pred</mi></mrow></msub><mo>+</mo><mn>0.05</mn></mrow></mfrac></msqrt></mrow></math></td>
<td class="label">2</td>
</tr></table>
<p>The root mean squared error between <em>y</em>
<sub>true</sub> and <em>y</em>
<sub>pred</sub> was
divided by <em>y</em>
<sub>pred</sub>, which served as a scaling
mechanism. Additionally,
to prevent division by zero, a small bias value of 0.05 was added
to the denominator.</p></section><section id="sec2.5"><h3 class="pmc_sec_title">2.5. Brief Model Outline</h3>
<p>The I-GAT framework
was implemented as a sequentially informed GAT-based architecture
across three phases. In phase 1, the model was trained to classify
ligand selectivity. This selectivity model consisted of multiple graph
attention layers whose trained weights were saved for later transfer.
In phase 2, a regression model was developed to predict IC50 values
(potency). To inform this model with prior knowledge, we initialized
the regression architecture using the trained weights from the previously
trained selectivity model. This form of transfer learning allowed
the regression model to build upon learned selectivity patterns. In
phase 3, the goal was to classify ligands into high-potency or low-potency
categories using both selectivity and potency information. To achieve
this, we constructed a dual-branch architecture that accepted the
weights from the selectivity network (phase 1), and from the regression
network (phase 2). Both branches passed through GAT layers and global
mean pooling before their outputs were concatenated and fed into a
multilayer perceptron (MLP). This allowed the model to jointly consider
both receptor selectivity and potency regression outputs for the final
classification task. This modular approach ultimately allowed for
the transmission of learned chemical insights across multiple prediction
tasks. More detail regarding the precise architecture is included
in the <a href="#sec3" class="usa-link">Results</a> section, along with streamlined
diagrams.</p></section><section id="sec2.6"><h3 class="pmc_sec_title">2.6. Attention Gradient Extraction</h3>
<p>After
phase 1 was completed, in order to prepare the model for attention
visualization in subsequent phases, 100% of the mGlu2, mGlu3, and
dual mGlu2/3 NAM data set was designated for training; after training,
the mode state was saved. Thereafter, one ligand at a time was selected
for attention visualization, and node features were generated in a
fashion identical to the preprocessing workflow. For each particular
ligand, the output was predicted using the weights of the trained
model, and the output node was examined to confirm that correct classification
occurred. Thereafter, a backward pass was made of the loaded model
with respect to the correctly indexed target node of interest. This
allowed for the weighing of each individual node feature, for each
particular node. Note, as many of the node features were one-hot encoded
in a manner that is incompatible with human comprehension, the average
values of these features were appended and mapped to the respective
nodes. Thus, for each node, the average gradient indicated the importance
of that particular atom to the final prediction.</p></section><section id="sec2.7"><h3 class="pmc_sec_title">2.7. Redesign Process</h3>
<p>After identifying
problem areas, the SMILES string of the selected molecule was inputted
onto JSME Molecule Editor hosted on <a href="https://www.cheminfo.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cheminfo.org/</a>. A host of synthetically feasible changes to
the structure could then be made. For each change, the SMILES string
of the edited molecule was recorded and thereafter evaluated using
the machine learning approach.</p></section><section id="sec2.8"><h3 class="pmc_sec_title">2.8. Model Comparisons for Regression</h3>
<p>To allow for direct comparisons of regression performance, we replicated
the molecular solubility prediction framework from Ahmad et al. More specifically, we used the 9943 compounds
derived from the Cui et al. data set as the training set. Then, we
evaluated the trained model’s capacity to generalize by performing
predictions on an independent test set (also from Cui et al.), which
consisted of 62 experimentally validated anticancer compounds. For
each molecule, we used its canonical SMILES representation along with
its aqueous solubility value (log S, which is measured in log mol/L).
Molecules were parsed using RDKit and converted into molecular graphs,
using the methods previously described in the Node Feature Selection
section. However, we applied one-hot encoding to capture the 31 unique
atoms that are present in this data set. Compared to the mGlu2/3 data
set, one fewer formal charge category was required, leading to 75
node features per ligand. The I-GAT model architecture previously
used for potency (IC50) regression was then trained on the Cui et
al. data set and evaluated on the independent test set of anticancer
compounds to evaluate the model’s capacity to generalize. A total of three independent runs with random
initialization were conducted to ensure that performance was replicable.</p></section><section id="sec2.9"><h3 class="pmc_sec_title">2.9. Model Comparisons for Classification</h3>
<p>In order to compare the classification performance of our model with
current state-of-the-art chemistry models, we adopted the data sets
used in Xu et al. We loaded four MoleculeNet benchmark databases,
namely the Blood-Brain Barrier Penetration (BBBP), β-secretase
enzyme (BACE), Human Immunodeficiency Virus (HIV), and Clinical toxicity
(ClinTox) data sets. Additionally, we applied the same methodology
for data loading as reported in the Xu et al. paper, with an 80:10:10
ratio for training, validation, and testing sets. The same preprocessing
from the regression task was used to generate canonical SMILES representations
along with the corresponding classification output. Hyperparameter
tuning was conducted using the Optuna module, allowing for the identification
of optimal hyperparameter values such as hidden neuron count, number
of attention heads, number of GAT layers, dropout rate, learning rate,
and weight decay. Once optimal configurations were identified, we
retrained the best-performing model for 500 epochs. Final performance
was assessed using the ROC-AUC metric, allowing for a direct comparison
against the state-of-the-art models reported by Xu et al. As with the regression task, three independent
runs with random initialization were used to ensure that classification
performance was reproducible and to evaluate model stability.</p></section></section><section id="sec3"><h2 class="pmc_sec_title">3. Results</h2>
<section id="sec3.1"><h3 class="pmc_sec_title">3.1. Data Preparation</h3>
<p>Model inputs utilized
a compiled data set of mGlu2 NAMs, mGlu3 NAMs, and dual mGlu2/3 NAMs.
Details of the molecular representation used to convert molecular
structures to model-interpretable encodings are included in the methods
section. For selectivity classification (task 1), 757 total ligands
were used. However, as not all compounds had IC50 values associated
with them within the original patents from which they were derived,
only 660 ligands could be included for both potency regression (task
2) and potency classification (task 3). More details about the origin
of the structures and data fractioning are included in the <a href="#sec2" class="usa-link">Materials and Methods</a> section.</p></section><section id="sec3.2"><h3 class="pmc_sec_title">3.2. Phase 1: Prediction Model for Ligand Selectivity
and Potency Metrics</h3>
<section id="sec3.2.1"><h4 class="pmc_sec_title">3.2.1. Phase 1, Task 1: Selectivity Classification</h4>
<p>To assess a particular drug candidate, it is critical to know if
it binds to off-target receptor(s). Similarly, to develop a targeted
neurotherapeutic for use in specific pathologies, such as Alzheimer’s
disease treatment, it is important to identify selective NAM ligands
for the mGlu2 receptor. In task 1, our
goal was to develop a model to accurately classify the receptor selectivity
of the input ligands.</p>
<p>From our available data, we assigned output
categories depending on the selectivity of ligands, which were mGlu2
NAMs, mGlu3 NAMs, or dual mGlu2/3 NAMs. We designed the first segment
of the model with three sequential graph attention layers. A simplified
representation of model architecture is depicted in <a href="#fig2" class="usa-link">Figure 
</a>. After each distinct layer,
20% of the nodes were subject to dropout as a form of regularization.
This was complemented by adding three output nodes corresponding to
each possible output category. As the model predictions are outputted
as logits, this method allows for correspondence with input labels.</p>
<figure class="fig xbox font-sm" id="fig2"><h5 class="obj_head">2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/c61d4673821d/ao5c02173_0002.jpg" loading="lazy" id="gr2" height="283" width="602" alt="2"></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Simplified
three-layer GAT model architecture tailored to task
1.</p></figcaption></figure><p>From the available data, an independent validation
set was created,
with 10% of the ligands (<em>n</em> = 75) designated for testing,
85% (<em>n</em> = 644) for training, and 5% (<em>n</em> = 38) for model validation. A second cross-validation set was created
after excluding the 10% of data designated for testing. Using the
StratifiedKFold, this remaining data (<em>n</em> = 682 ligands)
was split into 75% training, 5% validation, and 20% testing over five
folds for cross-validation. More detail pertaining to the data fractioning
is included in the methods section. After training for 250 epochs,
evaluation of the training loss and validation loss curves confirmed
that overfitting did not occur. The graph of training loss and validation
loss, for the independent validation set, is depicted in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S2</a>. Average selectivity accuracy across
all folds reached 97.65 ± 1.21%, with 98.81% accuracy for the
independent validation data set, indicating that our model demonstrated
high accuracy in the selectivity classification task. The selectivity
classification results for the five folds and the independent validation
data set are compiled in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S1</a>, indicating
that results were reproducible across folds.</p>
<p>Confusion Matrices,
depicted in <a href="#fig3" class="usa-link">Figure 
</a>, along with the classification reports (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Tables S2 and S3</a>) were used to further evaluate
the model for the 5-fold cross-validation, and for the independent
validation set, respectively. This analysis serves to indicate the
number of misclassifications for each target class. We intentionally
included dual mGlu2/3 NAMs to “confuse” the model, however,
the performance was still satisfactory for the cross-validation data
set (<a href="#fig3" class="usa-link">Figure 
</a>A,B).
Similar accuracy was approached by the independent validation set
as well, and only two ligands were misclassified out of 75 tested
ligands (<a href="#fig3" class="usa-link">Figure 
</a>C,D).
Ultimately, these findings demonstrate that this model segment was
capable of accurately identifying input ligand NAM selectivity for
mGlu2/mGlu3 receptors.</p>
<figure class="fig xbox font-sm" id="fig3"><h5 class="obj_head">3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/289d2ba9ac6b/ao5c02173_0003.jpg" loading="lazy" id="gr3" height="709" width="748" alt="3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Confusion matrices are depicted for the selectivity classification
task. (A) Numerical values for the 5-fold cross-validation set, (B)
with values normalized across the “true” category for
the 5-fold cross-validation set. (C) Numerical values for the independent
validation set, (D) with values normalized across the “true”
category for the independent validation set.</p></figcaption></figure></section><section id="sec3.2.2"><h4 class="pmc_sec_title">3.2.2. Phase 1, Task 2: IC50 Prediction</h4>
<p>IC50, or half maximal inhibitory concentration, is a measure to indicate
how much of a particular ligand is needed to inhibit a given biological
process or biological component by 50%. It is often used to assess
the potency of ligands. The IC50 value is inversely related to the
potency of the ligand; thus, ligands with lower IC50 values are considered
to be more potent. Measuring the IC50 values for a series of compounds
in experiments is expensive and time-consuming. Therefore, it is crucial
to develop a model to predict the IC50 values of ligands, enabling
comparisons of promising candidates more efficiently.</p>
<p>To perform
this task, only mGlu2 NAMs and mGlu3 NAMs with IC50 values were included.
As some ligands were not documented with their corresponding IC50
values, they were excluded in this task, resulting in only <em>n</em> = 660 ligands for analysis. From this corpus, an independent
validation set was created, with 10% of the ligands (<em>n</em> = 66) designated for testing, 85% (<em>n</em> = 561) for
training, and 5% (<em>n</em> = 33) for model validation. A
second cross-validation set was created after excluding the 10% of
data designated for testing. Using the StratifiedKFold, these remaining
ligands (<em>n</em> = 594 ligands) were split into 75% training,
5% validation, and 20% testing over five folds. More detail pertaining
to the data fractioning is included in the methods section. Two main
regression models were created. One “non-informed” model
functioned solely to predict IC50 values, using mGlu2 NAMs and mGlu3
NAM data as inputs. Another “informed” model transferred
the lessons learned from the selectivity task to the regression task.
This was achieved through transfer learning methodology, by loading
the weights of the three-layer selectivity model onto a new four-layer
model tasked with IC50 prediction. For both informed and noninformed
models, stable gradient descent was confirmed to have occurred over
the course of 400 epochs. Training and validation loss curves for
the independent validation set are represented by <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure 3</a>, indicating that overfitting did not occur. The simplified
architecture of the informed model is depicted in <a href="#fig4" class="usa-link">Figure 
</a>. This arrangement effectively
allows for the execution of a potency regression prediction via an
IC50 value using prior knowledge from the selectivity task.</p>
<figure class="fig xbox font-sm" id="fig4"><h5 class="obj_head">4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/fb06ba768f1f/ao5c02173_0004.jpg" loading="lazy" id="gr4" height="360" width="629" alt="4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Simplified
GAT model architecture tailored to task 2. The weights
of the selectivity classification network were transferred onto the
four-layer model subcomponents to “inform” the model.</p></figcaption></figure><p>To evaluate the predictive capacity of our model
about IC50 values,
we used mean absolute percentage error (MAPE) to measure the prediction
accuracy. This allowed for the measurement of the average percentage
difference between predicted IC50 values and actual IC50 values, for
the available data set. Here we denoted the measured in vitro experimental
IC50 values recorded in the original patent filings as the “actual”
values. For the 5-fold cross-validation data set, models that were
informed with selectivity weights yielded an average MAPE of 76.33
± 11.73%. Meanwhile, MAPE for regression prediction in the cases
where the models were not informed of selectivity averaged 103.15
± 37.14%, yielding a greater percentage error than the informed
prediction. This trend was also seen after the evaluation of the independent
validation data set, where the regression prediction informed with
selectivity weights yielded a MAPE of 75.44%. Meanwhile, the noninformed
model yielded a higher MAPE of 91.12%. A side-by-side comparison is
summarized <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S4</a>, further detailing
the superiority of the model that received more information, through
the loading of selectivity weights.</p>
<p>Regression of the predicted
vs actual log-transformed values is
depicted in <a href="#fig5" class="usa-link">Figure 
</a>, allowing for visualization of the value distributions. <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S4</a> details regression graphs of the predicted
vs actual IC50 values for the compiled five folds, and for the independent
validation data set. When examining the data, the normalized arrays
displayed significant correlation for the 5-fold cross-validation
data set. Additionally, the non-normalized IC50 values demonstrated
significant correlation for the independent validation data set when
assessed with Pearson’s correlation (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S5</a>). These results indicate that the informed model can accurately
predict the potency of our input ligands as quantifiable IC50 values
through the regression task.</p>
<figure class="fig xbox font-sm" id="fig5"><h5 class="obj_head">5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/5117f600b814/ao5c02173_0005.jpg" loading="lazy" id="gr5" height="484" width="697" alt="5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top graph depicts the regression output of the
GAT model (task
2) comparing actual versus predicted normalized IC50 values after
log transform, compiled across all five folds. The bottom graph depicts
the regression output of the GAT model (task 2) comparing actual versus
predicted normalized IC50 values after log transform for the independent
validation data set.</p></figcaption></figure></section><section id="sec3.2.3"><h4 class="pmc_sec_title">3.2.3. Phase 1, Task 3: Potency Classification</h4>
<p>The function of task 3 is to classify ligands based on potency,
with the intention of outputting “high” or “low”
as a binary measure of potency. This would allow for easier filtering
out low potency ligands when applied to large-volume drug discovery.
Additionally, accuracy values are easier to interpret, when compared
to the error metrics of regression values.</p>
<p>To cater to this
goal, the data was divided into high-potency or low-potency compounds
based on median cutoffs. For the mGlu2 ligands, any molecule with
an actual IC50 less than the median value of the data set, which was
74 nM, was designated as high potency (<em>n</em> = 175);
values at or above this cutoff were designated as low potency ligands
(<em>n</em> = 176). A separate median value of 1050 nM was
the defining cutoff for the mGlu3 data set, yielding <em>n</em> = 154 high potency mGlu3 ligands and <em>n</em> = 155 low
potency mGlu3 ligands. To leverage information learned from selectivity
classification and potency regression, we designated two segments,
the selectivity segment and the regression segment. The selectivity
segment appended weights from the selectivity tasks, retaining three
GAT-based layers, whereas the regression task received knowledge from
the regression task and was characterized by four layers, aligning
with the original model cores. At the terminus of each segment, global
mean pool was used to return graph-level outputs in a batch-wise format.
To incorporate and resolve information transferred from tasks 1 and
2, a multilayer perceptron (MLP) block was designated. The final model
architecture is simplified in <a href="#fig6" class="usa-link">Figure 
</a>.</p>
<figure class="fig xbox font-sm" id="fig6"><h5 class="obj_head">6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/c6536a042e74/ao5c02173_0006.jpg" loading="lazy" id="gr6" height="345" width="632" alt="6"></p>
<div class="p text-right font-secondary"><a href="figure/fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Simplified GAT model architecture tailored to task 3.
The weights
of the selectivity classification network (left side) and of the potency
regression network (right side) were transferred onto the model core.
The MLP subcomponent (gray nodes) was used to process both data streams.</p></figcaption></figure><p>After training, the model was evaluated to determine
the percentage
of correct predictions, for high or low potency classes. The model
that was informed with selectivity and potency weights reached 78.95
± 3.51% overall accuracy over five folds. This approach yielded
superior accuracy when compared with the model that simply classified
compounds as high or low potency without any selectivity or potency
information (noninformed model), which resulted in 75.93 ± 1.66%
classification accuracy. For the independent validation data set,
the informed model again yielded a higher potency classification accuracy
(81.82%), when compared to the accuracy of the noninformed model (75.76%
accuracy). This potency classification data is summarized <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S6</a>.</p>
<p>Confusion matrices are also used
to summarize the data in <a href="#fig7" class="usa-link">Figure 
</a>, along with the
classification reports <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Tables S7 and S8</a>. Across five folds, the model yielded 78.95 ± 3.51% accuracy
in correctly distinguishing high-potency versus low-potency ligands
using the informed model. For the independent validation data set,
the model yielded 81.82% accuracy in correctly distinguishing high-potency
versus low-potency ligands for the informed model. However, if the
same architecture was used to perform a classification prediction
using the same cutoff values for the same data set, accuracy was reduced
for the naïve model. For the cross-validation and independent
validation data sets, potency classification accuracies only reached
75.93 ± 1.66% and 75.76%, respectively. Thus, the transfer of
selectivity and potency regression information was necessary to increase
potency classification (task 3) accuracy. Overall, these results indicate
that the aforementioned transfer learning approach allowed for accurate
prediction of potency as discrete “high” or “low”
values, which will be helpful in the rapid screening of large volumes
of compounds regardless of differing IC50 distributions.</p>
<figure class="fig xbox font-sm" id="fig7"><h5 class="obj_head">7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/fdc694c89066/ao5c02173_0007.jpg" loading="lazy" id="gr7" height="741" width="786" alt="7"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Confusion matrices
are depicted for the potency classification
task. (A) Numerical values for the 5-fold cross-validation set, (B)
with values normalized across the “true” category for
the 5-fold cross-validation set. (C) Numerical values for the independent
validation set, (D) with values normalized across the “true”
category for the independent validation set.</p></figcaption></figure><p>In summary, during phase 1, the model was designed
to perform three
tasks. Task 1 aimed to predict selectivity classification, and the
model yielded excellent performance. In task 2, the model leveraged
selectivity information to perform an IC50 regression prediction with
low measured error. Finally, task 3 utilized information from selectivity
classification and potency regression to classify compounds as high
or low potency, with acceptable accuracy.</p></section></section><section id="sec3.3"><h3 class="pmc_sec_title">3.3. Phase 2: Attention Visualization</h3>
<p>In phase 1, we developed the model to accurately predict the properties
including selectivity and potency. In phase 2, further analysis was
conducted to understand what the machine learning model had learned.
The goal was to design an algorithm to determine the contribution
of each atom or functional group to the prediction results. The network
was constructed to enable the operator to train the model and examine
the composite gradients across the entire network. Proceeding onward,
all available data was used for training, with all three tasks performed
sequentially as previously described. Model states were then saved,
and evaluation was performed for task 1 output nodes, which correlated
to selectivity prediction (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S9</a>). Additionally,
analysis was performed on task 3 output nodes which represented the
potency classification prediction, as summarized in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S10</a>. For both task 1 and task 3, a backward pass was
performed with respect to the target node of interest. This allowed
the resulting gradients to be collected with respect to these target
nodes for their respective selectivity (task 1) or potency (task 3)
functions. This allowed for weighting of each individual node feature,
for each particular node. More details on gradient extraction are
provided in the <a href="#sec2" class="usa-link">Materials and Methods</a> section.</p>
<p>As an example, the mGlu2 ligand A041 was analyzed to understand
the contribution of each atom or functional group to selectivity,
as shown in <a href="#fig8" class="usa-link">Figure 
</a>. There are some positive gradients superimposed on some atom locations,
indicating that those specific atoms contribute favorably to the classification
of the molecule as a mGlu2 NAM ligand. Additionally, within this ligand,
A041, the negative gradients indicate atoms that negatively contribute
to this structure’s classification as a mGlu2 ligand. As an
example, the carbon atom with a negative gradient of −0.14
(circled in purple) denotes the atom that most negatively contributes
to the prediction of mGlu2 NAM selectivity. However, another nearby
carbon encircled in red is also a detrimental contributor to selectivity
according to the model’s knowledge base. In addition, a distant
nitrogen atom (circled in orange) also contributes negatively to the
selectivity prediction.</p>
<figure class="fig xbox font-sm" id="fig8"><h4 class="obj_head">8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/8101e9ab71ca/ao5c02173_0008.jpg" loading="lazy" id="gr8" height="1052" width="688" alt="8"></p>
<div class="p text-right font-secondary"><a href="figure/fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MGlu2 ligand A041 is analyzed for selectivity
interpretability.
(A) The original structure is depicted. (B) The resulting selectivity
gradient evaluation reveals the three most “problematic”
atoms, designated in purple, red, and orange highlights.</p></figcaption></figure><p>In a similar manner to attention visualization
for selectivity,
an examination of the relevant gradients for potency was performed,
with atom-level resolution. The potency classification (task 3) could
be adapted in a straightforward manner to offer interpretability.
The example analysis of A041 is depicted in <a href="#fig9" class="usa-link">Figure 
</a>. As indicated in the blue highlight, the
same carbon identified in the selectivity task also appears to contribute
negatively to high potency. While this multitask approach separately
allows for the identification of atoms that negatively contribute
to target selectivity and high potency, it also enables the identification
of common “problem areas” for both properties. If common
“problem areas” could be identified in selected molecules,
perhaps they could be replaced. In summary, we leveraged interpretability
mechanisms of our graph attention network in order to further explore
atomic contributions to potency.</p>
<figure class="fig xbox font-sm" id="fig9"><h4 class="obj_head">9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/738d3a0c6972/ao5c02173_0009.jpg" loading="lazy" id="gr9" height="1021" width="669" alt="9"></p>
<div class="p text-right font-secondary"><a href="figure/fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MGlu2 ligand A041 is analyzed for potency
interpretability. (A)
The original structure is depicted. (B) The resulting potency gradient
evaluation reveals the most “problematic” atom, circumscribed
in blue highlight.</p></figcaption></figure></section><section id="sec3.4"><h3 class="pmc_sec_title">3.4. Phase 3: Intelligent Optimization of Existing
Ligands</h3>
<p>With successful visualization of both selectivity
and potency gradients in phase 2, we sought to optimize the existing
ligands to design more potent and selective compounds in Phase 3.
Here we hypothesize that improving the “worst” performing
area of the initial molecule, which displayed the most negative gradient,
would improve the target property if the area displayed a less negative
gradient after the modification. To test this hypothesis, we analyzed
pairs of ligands from our data set, leveraging the already existing
in vitro data.</p>
<p>To investigate if selectivity could be improved
by improving negative gradient, we analyzed two ligands from our data
set, a nonselective ligand (BOTH112) and a mGlu2 selective ligand
(BOTH116). For BOTH112, the mGlu2 EC<sub>50</sub>/mGlu3 EC<sub>50</sub> ratio was 0.466, indicating a relatively nonselective NAM function.
For BOTH116, the mGlu2 EC<sub>50</sub>/mGlu3 EC<sub>50</sub> ratio
was less than 0.027, indicative selectivity for mGlu2. When analyzing
their gradients, we found that a nitrogen atom presented with the
most negative gradient (−0.31, red highlight in <a href="#fig10" class="usa-link">Figure 
</a>) in BOTH 112. When the nitrogen
atom presenting with the most negative gradient in BOTH 112 is substituted
with carbon in BOTH116, the gradient became less negative at that
site (−0.10, blue highlight in <a href="#fig10" class="usa-link">Figure 
</a>), suggesting attenuating the negativity
of gradient may improve mGlu2 selectivity. We further analyzed BOTH116
with another nonselective ligand BOTH114 (mGlu2 EC<sub>50</sub>/mGlu3
EC<sub>50</sub> ratio of 0.29). Again, the improvement of the negative
gradient surrounding the nitrogen atom of BOTH114, into the less negative
carbon atom of BOTH116, is correlated with improved mGlu2 selectivity,
as illustrated <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S5</a>. Ultimately, these
findings imply that improving the most negative gradient site might
be used as a strategy to improve selectivity.</p>
<figure class="fig xbox font-sm" id="fig10"><h4 class="obj_head">10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0010.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/fa7456150582/ao5c02173_0010.jpg" loading="lazy" id="gr10" height="393" width="695" alt="10"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top panel depicts the
effect of the structural modification without
superimposed selectivity gradients; the bottom panel depicts the structures
with superimposed potency gradients. The negatively performing region
of the starting molecule, BOTH112, is highlighted in red. After the
substitution of the nitrogen with the carbon atom (blue highlight),
the target areas show a favorable gradient change. This correlated
to a favorable change in predicted selectivity for the target area
in ligand BOTH116.</p></figcaption></figure><p>Next, we sought to evaluate the capacity of this
model to perform
potency optimization. Here, we analyzed two ligands with similar structures
but significantly different IC50 values, A273 and A275 (<a href="#fig11" class="usa-link">Figure 
</a>). The primary
structural difference between these two compounds lies in the functional
group at a specific location: A273 contains a nitrile group, whereas
A275 features an amide group at the same position. The nitrile group
in A273 (highlighted in red in <a href="#fig11" class="usa-link">Figure 
</a>) exhibits a negative gradient, indicating
a detrimental contribution to the prediction of high ligand potency.
In contrast, the amide group in A275 (highlighted in blue in <a href="#fig11" class="usa-link">Figure 
</a>) displays a less
negative gradient, suggesting it reduces the adverse effect on potency.
As depicted in <a href="#fig11" class="usa-link">Figure 
</a>, substituting the nitrile group in A273 with the amide group of
A275 attenuates the most negative gradient in the molecule. Indeed,
this replacement drastically improved the IC50 value from 173 nM (A273)
to 7 nM (A275), implying that modifying the region with the most negative
gradient might improve potency. Again, it is important to note that
the only difference between both molecules is the replacement of the
nitrile group with the amide group. We further tested this hypothesis
with another ligand pair with similar structures but with different
IC50 values, A026 and A041. A026 is a low-potency compound with an
IC50 of 416 nM, whereas A041 has a much higher potency with an IC50
of 12 nM. As depicted in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S6</a>, the
carbon atom in a nitrile group of A026 appears to have the most negative
gradient (highlighted in red), contributing negatively to the high-potency
prediction. When this “poor-performing” group of A026
was replaced with an amide group in the ligand A041, the gradient
on the carbon atom became positive (highlighted in blue in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S6</a>), again suggesting that improving the
most negative gradient might be an effective strategy to improve potency.</p>
<figure class="fig xbox font-sm" id="fig11"><h4 class="obj_head">11.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0011.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/a773ea417e04/ao5c02173_0011.jpg" loading="lazy" id="gr11" height="479" width="746" alt="11"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Potency
optimization for the ligand A273. The top panel depicts
the effect of the structural modification without superimposed potency
gradients; the bottom panel depicts the structures with superimposed
potency gradients. The negatively performing region of the starting
molecule, A273, is highlighted in red. After the substitution of the
nitrile group with the amide group (blue highlight), the target areas
show a favorable gradient change. This correlated to a favorable change
in predicted potency for the target area in ligand A275.</p></figcaption></figure><p>As seen by these examples, there does appear to
be an improvement
in potency when nitrile groups are replaced with amide groups, for
mGlu2 NAMs. It is also interesting to note that for the 14 mGlu2 NAMs
with nitrile groups, the mean IC50 value is 413.57 nM, with a median
value of 157.50 nM. These values are much higher than the mean IC50
value for the mGlu2 data set (78.65 nM), and the median value of 74
nM. This data is summarized in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S2</a>.</p>
<p>This correlation of underlying gradients with potency was
not restricted
to mGlu2 ligands. We randomly selected a low-potency mGlu3 NAM ligand
Be53 (IC50 of 4270 nM) and identified its higher-potency counterpart
Be38 (IC50 of 980 nM). A similar trend was observed, and the improvement
of mGlu3 IC50 correlated with target gradient improvement. As illustrated
in <a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S7</a>, the “worst”
performing area was a nitrogen atom (with a gradient value of −0.19)
in Be53. Substitution to a carbon atom changed the gradient to 0.00,
which is correlated with a drastic potency improvement. In another
example, the low potency mGlu3 ligand, BEM21, with an IC50 of 4070
nM, was assessed. If the trifluoromethoxy group in this molecule had
been replaced with the nitrile group seen in BEM18, the actual IC50
would have improved to 784 nM. Concordantly, the changed regions show
favorable gradient change (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S8</a>),
becoming less negative with this process. In summary, for both mGlu2
and mGlu3 ligands, leveraging underlying gradients allows for localization
of the “worst performing” atoms or groups. Additionally,
making favorable changes according to underlying gradients allows
for the improvement of IC50.</p>
<p>Furthermore, we investigated the
reproducible interpretation of
the model. We conducted three separate model runs with random initialization
and examined the mGlu2 NAM A041. While the selectivity gradients showed
slight variance when the model was run in triplicates, the values
were still very similar (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S9</a>). Additionally,
the gradients with the most negative values were localized to the
same regions for each run. Furthermore, the potency gradients were
similar between the triplicate runs, indicating the stability of the
model (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S10</a>). This indicates a reliable
and replicable interpretation has been reached, highlighting the strength
of this model through its reproducible interpretability.</p>
<p>To
further expand the applicability of the interpretable GAT model,
we sought to redesign an existing ligand into a novel one to enhance
its selectivity and potency. We examined the list of mGlu2 ligands
with nitrile groups (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Table S12</a>) and picked
ligand A053 as our example. A053 displayed the highest mGlu2 IC50
value of 3059 nM, indicating that this was the least potent of the
group. Selectivity interpretability was examined using the methods
described previously. We identified a carbon atom in a nitrile group
hosting the most negative gradient. In a similar manner, potency interpretability
was also examined. Yet again, this carbon atom in the nitrile group
yielding the most negative gradient. Indeed, for both selectivity
and potency, this carbon atom that was part of the nitrile group was
the “problem area”. Thereafter, we substituted the nitrile
group with the amide group, a substitution that had previously yielded
more potent compounds, as indicated by the compounds within the existing
database. When analyzed for selectivity, the substitution appeared
to be more favorable, according to the ML model’s knowledge
base, as indicated by the less negative gradients (<a href="#fig12" class="usa-link">Figure 
</a>). Additionally, this change
yielded gradients of less negative magnitude for the potency prediction,
which implicates the generation of a higher-potency compound according
to the ML model’s knowledge base (<a href="#fig13" class="usa-link">Figure 
</a>).</p>
<figure class="fig xbox font-sm" id="fig12"><h4 class="obj_head">12.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0012.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/30334eb9d772/ao5c02173_0012.jpg" loading="lazy" id="gr12" height="472" width="662" alt="12"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig12/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top panel depicts the effect of the structural
modification without
selectivity gradients; the bottom panel depicts the structures with
superimposed selectivity gradients. The problem region of the ligand
A053 is highlighted in red. After the substitution of the nitrile
group with an amide group, the subsequent novel structure is analyzed
for selectivity interpretability. The target area shows a favorable
gradient change, indicating a favorable change in predicted selectivity
for the “problem area”, now highlighted in green within
the novel ligand, KE_01.</p></figcaption></figure><figure class="fig xbox font-sm" id="fig13"><h4 class="obj_head">13.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332587_ao5c02173_0013.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9549/12332587/4d3b8a60df6a/ao5c02173_0013.jpg" loading="lazy" id="gr13" height="566" width="792" alt="13"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig13/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top panel depicts the effect of the structural modification
without
potency gradients; the bottom panel depicts the structures with superimposed
potency gradients. The problem region of the ligand A053 is highlighted
in red. After the substitution of the nitrile group with an amide
group, the subsequent novel structure is analyzed for potency interpretability.
The target area shows a favorable gradient change, indicating a favorable
change in predicted potency for the “problem area”,
now highlighted in green within the novel ligand KE_01.</p></figcaption></figure><p>After this substitution, we generated a novel compound,
named KE_01,
and then predicted its properties using our prediction models. Evaluation
by the model yields predictions that this ligand is a selective mGlu2
ligand (task 1 prediction), with a predicted IC50 value of 55.72 nM
(task 2 prediction), which is less than the median value (74 nM) of
the mGlu2 data set. Separate evaluation by the task 3 segment of the
model further demarcates this molecule as a high-potency ligand, predicted
to be much more potent than the predecessor, A053, which had an IC50
value of 3059 nM. At this time, this molecule does not exist in the
literature, as determined by SMILES search on PubChem and in general
Google search. While biological mGlu2 NAM selectivity and potency
need to be confirmed, further studies can be undertaken to evaluate
this novel ligand structure in vitro. The SMILES of this novel ligand,
(KE_01), is as follows: NC­(O)­c4cc­(c1ccc­(F)­cc1)­c3ccc­(CN2CCCC2O)­cc3n4.</p>
<p>In brief, our work consists of three phases. The first phase centered
around designing an ML model that accurately predicted the target
properties of our data set, namely selectivity and potency. After
achieving this goal, phase two focused on the interrogation of the
model to identify the “problem” areas of select molecules.
In phase 3, we resolved these problem sites with a targeted optimization
process and then used the ML model to reevaluate the optimized ligand
to see if modifications were favorable. Leveraging the interpretability
of this model led to the generation of one novel ligand, which will
be optimized further in the near future.</p></section><section id="sec3.5"><h3 class="pmc_sec_title">3.5. I-GAT Comparisons to Current Models</h3>
<p>While our model demonstrated excellent performance in predicting
properties for our specific data set, the question remains whether
it will work for other data sets as well, and for other chemical properties.
To investigate this further, we employed a regression data set gathered
by Cui et al. We compared our model against other state-of-the-art
models, using the data already reported by Ahmad et al. Additionally,
we used RMSE, along with <em>R</em>
<sup>2</sup> values, to
make a fair comparison. Using the methods employed by Ahmad et al.,
we noted that the performance of our I-GAT model was marginally better
in terms of the <em>R</em>
<sup>2</sup> metric, yielding a
value of 0.543 ± 0.065 over three runs, when compared to 0.52
from the prior best-performing model. Additionally, our model delivered
a lower RMSE value than the other state-of-the-art models, as detailed
in <a href="#tbl1" class="usa-link">Table 
</a>. The previous
best-performing model, AttentiveFP, yielded an RMSE of 0.61, which
was surpassed by the RMSE of our model, which yielded a value of 0.563
± 0.040 over three runs. Ultimately,
these findings strongly support the capability of our regression arm
to match or exceed the performance of state-of-the-art models for
predicting other properties of unique data sets with minimal modifications.</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">1. Comparative Performance of Multiple
ML Models for Solubility Prediction<sup></sup>
.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="char" char="." span="1">
<col align="char" char="." span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">Model</th>
<th align="center" colspan="1" rowspan="1">R<sup>2</sup>
</th>
<th align="center" colspan="1" rowspan="1">RMSE</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">GIN-based
GNN</td>
<td align="center" colspan="1" rowspan="1">0.21</td>
<td align="center" colspan="1" rowspan="1">0.78</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SGConv-based GNN</td>
<td align="center" colspan="1" rowspan="1">0.09</td>
<td align="center" colspan="1" rowspan="1">1.98</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GAT-based GNN</td>
<td align="center" colspan="1" rowspan="1">0.38</td>
<td align="center" colspan="1" rowspan="1">0.69</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14 layers ResNet</td>
<td align="center" colspan="1" rowspan="1">0.13</td>
<td align="center" colspan="1" rowspan="1">0.82</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">20 layers ResNet</td>
<td align="center" colspan="1" rowspan="1">0.41</td>
<td align="center" colspan="1" rowspan="1">0.68</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">26 layers ResNet</td>
<td align="center" colspan="1" rowspan="1">0.07</td>
<td align="center" colspan="1" rowspan="1">0.85</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AttentiveFP-based
GNN</td>
<td align="center" colspan="1" rowspan="1">0.52</td>
<td align="center" colspan="1" rowspan="1">0.61</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">I-GAT</td>
<td align="center" colspan="1" rowspan="1">0.543 ± 0.065</td>
<td align="center" colspan="1" rowspan="1">0.563 ± 0.040</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tbl1fn1">
<sup>a</sup><p class="display-inline">Except for the I-GAT data, all
other metrics have already been reported in the manuscript from Ahmad
et al. I-GAT metrics are reported as mean ± standard deviation
from three independent runs.</p>
</div></div></section><p>We also investigated the potential for our model to
apply to classification
data sets as well. To benchmark the classification capabilities of
our I-GAT model, we compared our performance against the highest-performing
models reported for four MoleculeNet classification data sets, namely
BBBP, BACE, HIV, and ClinTox. ROC-AUC scores (mean ± standard
deviation over three runs) are presented in <a href="#tbl2" class="usa-link">Table 
</a>. For the BACE data set, I-GAT achieved the
highest ROC-AUC of 86.6 ± 0.6, marginally outperforming ChemXTree
(86.2 ± 0.5), the previous best performing model. In the HIV
classification task, I-GAT again achieved the top performance, with
a ROC-AUC of 81.6 ± 0.8, exceeding the scores of Uni-Mol (80.8
± 0.3), which was previously the highest performing model. For
the ClinTox data set, ChemXTree remained the top performer with a
ROC-AUC of 92.3 ± 0.8. While I-GAT did not exceed this result,
it still yielded exceptional performance with a ROC-AUC score of 88.0
± 2.9, which outperformed the majority of other reported models.
In the BBBP task, I-GAT achieved a ROC-AUC of 70.6 ± 1.9, placing
it in the middle of the range relative to other state-of-the-art chemistry
models. In summary, these results demonstrate that I-GAT consistently
matches performance on multiple molecular classification benchmarks.
However, it exceeded state-of-the-art models with regard to BACE and
HIV benchmarks.
</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">2. Comparative Performance of Multiple
ML Models for Classification Tasks<sup></sup>
.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1">
<col align="char" char="±" span="1">
<col align="char" char="±" span="1">
<col align="char" char="±" span="1">
<col align="char" char="±" span="1">
</colgroup>
<thead><tr>
<th align="center" colspan="1" rowspan="1">Model</th>
<th align="center" colspan="1" rowspan="1">BBBP</th>
<th align="center" colspan="1" rowspan="1">BACE</th>
<th align="center" colspan="1" rowspan="1">HIV</th>
<th align="center" colspan="1" rowspan="1">ClinTox</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">D-MPNN</td>
<td align="center" colspan="1" rowspan="1">71.0 ± 0.3</td>
<td align="center" colspan="1" rowspan="1">80.9 ± 0.6</td>
<td align="center" colspan="1" rowspan="1">77.1 ± 0.5</td>
<td align="center" colspan="1" rowspan="1">90.6 ± 0.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Attentive FP</td>
<td align="center" colspan="1" rowspan="1">64.3 ± 1.8</td>
<td align="center" colspan="1" rowspan="1">78.4 ± 0.02</td>
<td align="center" colspan="1" rowspan="1">75.7 ± 1.4</td>
<td align="center" colspan="1" rowspan="1">84.7 ± 0.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N-GramRF</td>
<td align="center" colspan="1" rowspan="1">69.7 ± 0.6</td>
<td align="center" colspan="1" rowspan="1">77.9 ± 1.5</td>
<td align="center" colspan="1" rowspan="1">77.2 ± 0.1</td>
<td align="center" colspan="1" rowspan="1">77.5 ± 4.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N-GramXGB</td>
<td align="center" colspan="1" rowspan="1">69.1 ± 0.8</td>
<td align="center" colspan="1" rowspan="1">79.1 ± 1.3</td>
<td align="center" colspan="1" rowspan="1">78.7 ± 0.4</td>
<td align="center" colspan="1" rowspan="1">87.5 ± 2.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PretrainGNN</td>
<td align="center" colspan="1" rowspan="1">68.7 ± 1.3</td>
<td align="center" colspan="1" rowspan="1">84.5 ± 0.7</td>
<td align="center" colspan="1" rowspan="1">79.9 ± 0.7</td>
<td align="center" colspan="1" rowspan="1">72.6 ± 1.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GROVERbase</td>
<td align="center" colspan="1" rowspan="1">70.0 ± 0.1</td>
<td align="center" colspan="1" rowspan="1">82.6 ± 0.7</td>
<td align="center" colspan="1" rowspan="1">62.5 ± 0.9</td>
<td align="center" colspan="1" rowspan="1">81.2 ± 3.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GROVERlarge</td>
<td align="center" colspan="1" rowspan="1">69.5 ± 0.1</td>
<td align="center" colspan="1" rowspan="1">81.0 ± 1.4</td>
<td align="center" colspan="1" rowspan="1">68.2 ± 1.1</td>
<td align="center" colspan="1" rowspan="1">76.2 ± 3.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GraphMVP</td>
<td align="center" colspan="1" rowspan="1">72.4 ± 1.6</td>
<td align="center" colspan="1" rowspan="1">81.2 ± 0.9</td>
<td align="center" colspan="1" rowspan="1">77.0 ± 1.2</td>
<td align="center" colspan="1" rowspan="1">79.1 ± 2.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MolCLR</td>
<td align="center" colspan="1" rowspan="1">72.2 ± 2.1</td>
<td align="center" colspan="1" rowspan="1">82.4 ± 0.9</td>
<td align="center" colspan="1" rowspan="1">78.1 ± 0.5</td>
<td align="center" colspan="1" rowspan="1">91.2 ± 3.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GEM</td>
<td align="center" colspan="1" rowspan="1">72.4 ± 0.4</td>
<td align="center" colspan="1" rowspan="1">85.6 ± 1.1</td>
<td align="center" colspan="1" rowspan="1">80.6 ± 0.9</td>
<td align="center" colspan="1" rowspan="1">90.1 ± 1.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Uni-Mol</td>
<td align="center" colspan="1" rowspan="1">72.9 ± 0.6</td>
<td align="center" colspan="1" rowspan="1">85.7 ± 0.2</td>
<td align="center" colspan="1" rowspan="1">80.8 ± 0.3</td>
<td align="center" colspan="1" rowspan="1">91.9 ± 1.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ChemXTree</td>
<td align="center" colspan="1" rowspan="1">75.6 ± 0.6</td>
<td align="center" colspan="1" rowspan="1">86.2 ± 0.5</td>
<td align="center" colspan="1" rowspan="1">80.6 ± 0.5</td>
<td align="center" colspan="1" rowspan="1">92.3 ± 0.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">I-GAT</td>
<td align="center" colspan="1" rowspan="1">70.6 ± 1.9</td>
<td align="center" colspan="1" rowspan="1">86.6 ± 0.6</td>
<td align="center" colspan="1" rowspan="1">81.6 ± 0.8</td>
<td align="center" colspan="1" rowspan="1">88.0 ± 2.9</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tbl2fn1">
<sup>a</sup><p class="display-inline">Except for the new I-GAT data,
all other metrics have already been reported in the manuscript from
Xu et al. I-GAT metrics are reported
as mean ± standard deviation from three independent runs.</p>
</div></div></section></section></section><section id="sec4"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>The design of the model
required careful alignment with an appropriate
molecular input representation. For atom identity, instead of using
atomic numbers, we encoded the chemical symbol based on a permitted
list of atoms. In addition to this atom-name encoding, we also included
the atomic mass. While this seems redundant, including this information
could allow for prioritization of rarer elements, especially considering
that lower-weight elements such as carbon are more common in chemical
structures. We encoded information pertaining to hydrogen atoms by
assigning a numerical value equivalent to the total number of hydrogens
bound to a single atom, which we superimposed as a node feature at
that atom. Other data inputs focused on transmitting data about the
three-dimensional structure of a molecule. These inputs included Gasteiger
(partial) charges and hybridization, which were originally explored
by Goh et al. As a whole, this data preparation
serves to transmit information about the arrangement and structure
of the molecule.</p>
<p>To increase the predictive capacity of our
ML model, we included
the following values correlating with the physicochemical properties
of molecules. We included implicit valence, as this quantification
of reaction capacity could correlate with ligand stability. Formal charge is a computed property that serves
as a proxy for charge transfer, which can be useful in predicting
reactivity.<em>
−

</em> The number of directly bonded neighbors, called degree,
is also chemically relevant. Considering that isolated atoms display
the tendency to display more reactivity when compared to an atom with
more bonds, degree may potentially correlate with ligand–receptor
interaction. Explicit valence includes
bonds that are connected to hydrogen atoms, in addition to all the
bonds that a particular atom has to its surrounding atoms. In the
realm of chemical simulations, explicit valence allowed for the description
of the polarizability, flexibility, and dissociation capacity of water
in the context of proton transfer. The
scale covalent radius was incorporated; as shorter bond lengths imply
stronger bonds, and vice versa, this information could transmit data
about the physical properties of chemical structures.<em>
,
</em> When considering features of a single molecule, van der Waals radius
can lend information about molecular geometry, which has implications
for factors such as chemical reactivity and even selectivity in some
contexts.<em>
,
</em> The inclusion of these values could allow
the model to recognize similar computational “landscapes”
between molecules of interest, which may be corollaries of receptor
selectivity or potency in the context of metabotropic glutamate receptors.
While this work offers atom-level resolution, some node features,
such as hybridization, consider neighboring atoms and bonds. Thus,
with our particular encoding, the atom-level resolution is paired
with metrics that consider macro-level features.</p>
<p>When combined
with this style of molecular representation, we designed
our network with the capacity to perform three tasks and leveraged
transfer learning to inform each subsequent task. For task 1, simple
classification was performed, as the model predicted ligand selectivity
with high accuracy. For task 2, regression was performed, as the model
estimated the IC50 values of individual input ligands, yielding an
acceptable error. Improved performance was noted when the classification
weights from task 1 were broadcasted into the attention layers of
the model for task 2, serving as a starting point. Initially, the
model yielded adequate performance for task 2 but appeared highly
unstable. Performance and stability both increased when we added another
GAT layer. This fourth layer could be surmised to add “flexibility”,
allowing the model to resolve previous knowledge of selectivity with
new knowledge of potency, allowing for stable gradient descent. Adding
a fifth layer decreased performance, which is succinctly explained
by the oversmoothing phenomenon that arises with excessively deep
GNN architecture, which leads to reduced predictive power. It is intriguing to note that this same oversmoothing
effect existed in the selectivity task as well, and thus we tuned
layer depth with this consideration.</p>
<p>The advantages of transfer
learning were evidenced in task 2 by
the drastic differences between the MAPE values of the informed regression
model when compared with the noninformed regression model. The improved
performance resulting from the transfer of selectivity weights could
be explained by multiple factors. There could be a nonlinear relationship
between selectivity and potency, although concrete evidence of this
relationship does not exist in the literature. Additionally, the IC50
value distributions of the mGlu2 and mGlu3 ligands were fundamentally
different. Thus, broadcasting the highly accurate selectivity information
could allow the machine learning model to learn about this inherent
distribution inequality. Ultimately, using the informed model is more
representative of real-life use cases, especially in instances where
currently existing ligands display varying potency for target receptors.
In the drug discovery process, researchers would need to identify
the target receptor of a ligand before selecting the most potent ones.</p>
<p>To cater to large-volume data handling, potency classification
was also integrated with task 3. With this classification output,
the model sought to determine if a ligand displayed low or high potency
for the target class. Having a concise method to exclude low-potency
compounds would be ideal, especially as data volume increases. To
perform this function, the network would have to be designed in a
manner such that the high selectivity accuracy and the low MAPE of
the repression prediction could be leveraged to inform the potency
classification. While more GAT-based layers were added, the network
again appeared to experience the phenomenon of oversmoothing yet again.
Thus, we designated a shallow MLP to resolve the outputs of the two
segments. There was still instability noted, theorized to be due to
difficulty resolving both selectivity and potency regression weights.</p>
<p>To address this issue, for the first 100 epochs, the weights of
the selectivity segment were frozen. Notably, when we froze the regression
segment, training was unstable. Ultimately, these results lead to
the assumption that allowing for task 3 to be “biased”
in favor of the potency prediction inputs, allows for stability of
the loss landscape. After 100 epochs, the weights of the regression
segment were unfrozen. Although there was a noticeable spike in both
training and validation loss, stable training ensued thereafter. The
comparison between partially frozen loss curves (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S11</a>) and unfrozen loss curves (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Figure S12</a>) demonstrates the superiority of the partially
frozen method, which is paralleled by increased accuracy. It is important
to note that unfortunately, some overfitting did occur, even with
partial layer freezing. This could be due to the data complexity,
as resolving two separate molecular characteristics is a difficult
task for the model. Nonetheless, similar to the selectivity prediction,
the potency classification prediction also achieved high accuracy.</p>
<p>Building on the model’s strong performance, we next sought
to investigate why certain ligands were predicted to exhibit ideal
properties by exploring the interpretability of the model’s
outputs. Before discussing the interpretable output, it is important
to consider that computational inputs are difficult to understand
from a human perspective. However, identifying the relative contributions
of each atom to a target property can allow chemists to visualize
problem areas. To achieve this task, after completion of training
tailored to selectivity and potency prediction, we examined the model’s
hidden state with gradient evaluation. While the gradients are relative
and are only comparable intramolecularly, the decreased magnitude
of the gradients for potency in comparison to selectivity could be
explained in a few ways. The process of multitask learning through
three discrete tasks, along with the weight mechanism intrinsic to
attention networks, most likely induced a scaling effect. As the network
trained and incorporated information from multiple tasks, the gradients
that were propagated reduced in magnitude to permit stable gradient
descent. Additionally, the added layers of the GATs tailored to task
2 and task 3 may have contributed to some degree of oversmoothing.
Random initialization and subsequent training could yield discrepancies
due to the stochastic nature of ML models, especially with such a
low sample size. However, this was not the case; ultimately, the relative
reproducibility of the predictions and their underlying gradients
across multiple runs is very interesting. Taken as a composite, this
yields evidence of an extremely stable, multifunction selectivity
and potency interpretability model using graph architecture.</p>
<p>We further leveraged this robust interpretability evaluation to
identify trends associated with target properties. For the two assessed
mGlu2 ligands, amide substitution of the original nitrile group appeared
to correlate with increased potency, as confirmed by ground truth
values. For the available data set, the average median and mean IC50
values for the mGlu2 NAMs with nitrile groups were higher than the
corresponding values of the entire mGlu2 NAM data set. While it is
difficult to conclusively state that the presence of nitrile groups
is detrimental to mGlu2 potency, the data suggests this possibility.
At this time, there is no literature indicating whether nitrile groups
correlate with reduced mGlu2 potency or influence selectivity. As
this has not been previously reported in the literature, this could
be a valuable direction for future study, and could allow us to fully
validate the interpretability mechanism.</p>
<p>One of the limitations
of leveraging interpretability to optimize
target characteristics stems from the data corpus. Due to the limitation
of our data set, our model was only evaluated for the ligands with
similar scaffolds. However, the possibility that our ligand could
go from displaying an IC50 of 3059 nM to a theoretical IC50 of 55.72
nM with one targeted modification inspires optimism. Of note, our
computational methods still need to be validated with in vitro experiments
in future studies. In the meantime, further optimization of this novel
ligand could take place. From the structure-based approach, docking
studies could be used to optimize ligand characteristics. Docking
maps can be generated to find favorable interactions with the receptor.
Structural modification and transplantation of functional groups can
be combined with our approach to evaluate if favorable binding can
be increased to the target receptor.</p>
<p>While recent advances in
lead compound optimization have favored
end-to-end approaches, our choice to implement a modular, three-phase
design for I-GAT was intentional and strategic. We designed our pipeline
reflecting how a trained chemist would undertake ligand optimization.
Unlike end-to-end models, which often obscure the internal reasoning
behind predictions, our staged architecture enables the extraction
of intermediate outputs, such as attention gradients, which can be
visualized and validated by experts. Our architecture isolates key
tasks, allowing for more granular insight into model behavior and
decision-making at each step. The model’s interpretability
facilitates rational, structure-guided modifications by highlighting
detrimental regions, such as a nitrile group, that can be strategically
substituted to improve both potency and selectivity. While the I-GAT
model utilizes components grounded in established graph architectures,
its staged, multitask design paired with gradient-based interpretability
provides a novel integration tailored to ligand optimization. In particular,
we designed custom training flows and attention-based interpretability
methods to deliver atomic-resolution explanations. As seen by multiple
examples, the model performs at an atom-level resolution with the
capacity to identify individual poor-performing atoms. Simultaneously,
this model can also consider granular, macro-level details of input
chemical ligands. This lends further differentiation of the capability
of our model when compared to current chemistry interpretability models.</p>
<p>These methods expand beyond traditional black-box modeling and
provide actionable insights for medicinal chemistry. Moreover, this
modular design allows for flexibility and adaptability. Each task
can be removed, retrained, or replaced, allowing the framework to
accommodate different types of molecular inputs or output properties
without requiring a full model redesign. This plug-and-play structure
is particularly valuable in iterative experimental workflows, where
model interpretability can inform compound synthesis and subsequent
rounds of design. To further demonstrate the generalizability of our
approach, we also leveraged this modularity to conduct model comparisons
across a diverse range of data sets.</p>
<p>While searching for comparative
models, we found that existing
literature primarily focuses on one output prediction. While there
are GNN-based models that employ transfer learning, this is in the
context of integrating low-fidelity and high-fidelity data with respect
to a single output property prediction. To the best of our knowledge,
no existing GNN models perform multifunctional property prediction
while incorporating transfer learning from multiple tasks to yield
better informed predictions. Thus, we were unable to find a benchmark
model in the existing literature to compare to our model while exploring
all properties of the data set in the manner detailed in the paper. However, we sought to compare our model performance
to state-of-the-art models using existing databases for single-property
prediction.</p>
<p>In this work, we initially trained I-GAT on a relatively
small
data set focused on mGlu2 and mGlu3 receptors, particularly for potency
prediction via regression in the second task. While our model demonstrated
excellent performance on the original data set, its performance may
vary depending on the input data sets. To address this issue, we trained
our I-GAT on a large solubility regression data set and predicted
on an independent data set, following the methodology of Ahmad et
al. This allowed us to incorporate a regression task and a data set
for which the model was not explicitly tuned. Despite this shift in
task objective, I-GAT outperformed AttentiveFP, which was the previously
best-performing model reported by Ahmad et al. Our model yielded a
lower RMSE of 0.563 ± 0.040 compared to the 0.61 RMSE value from
AttentiveFP. Additionally, we were able to attain a higher <em>R</em>
<sup>2</sup> score of 0.543 ± 0.065 compared to 0.52
from the prior state-of-the-art model. These results suggest that I-GAT has the capacity to yield exceptional
performance for predicting other physicochemical properties, and that
its regression prediction capacity was not restricted to potency.</p>
<p>Similarly, our original classification experiments from Task 1
were limited to ligand selectivity prediction for mGlu2 and mGlu3
receptors. To test I-GAT’s broader applicability, we examined
four classification data sets derived from MoleculeNet. The BBBP data
set evaluates blood–brain barrier permeability, which is an
important feature for designing CNS drugs. The BACE focuses on ligands
that are human beta-secretase 1 (BACE-1) inhibitors; we used the qualitative
binary label to form a fair comparison to Xu et al. The HIV database
classifies compounds for their ability to inhibit viral replication,
and ClinTox classifies ligands based on toxicity. These data sets
are diverse in terms of molecular characteristics, data set counts,
chemical structure variability, and the available properties. However,
I-GAT achieved the highest performance on two particular benchmarks,
namely BACE (with ROC-AUC of 86.6 ± 0.6) and HIV (with ROC-AUC
of 81.6 ± 0.8), outperforming state-of-the-art models. For the
ClinTox data set, I-GAT maintained a strong performance (88.0 ±
2.9), exceeding the performance of most comparison models. On the
BBBP data set, however, I-GAT yielded a midrange result (70.6 ±
1.9), while remaining competitive with several established models.
While investigating this further, we noted a paper referencing duplicates,
mischarged atoms, and conflicting labels in the BBBP data set. In
some instances, identical molecules were labeled both as BBB-penetrant
and nonpenetrant, which can degrade model performance. Additionally,
the presence of chemically invalid atoms, such as uncharged tetravalent
nitrogen atoms, can also degrade model performance. Ultimately, the aforementioned errors could impair learned
structure–property relationships during training.</p>
<p>Of
note, while we employed Optuna to tailor hyperparameters to
each task, we did not tailor the approach to these data sets. Additionally,
the strength of our model comes from its transfer learning capacity.
With these data sets, we were not able to leverage the full reach
of our model. Despite these constraints, I-GAT still delivered performance
comparable to leading models. These findings indicate that I-GAT demonstrates
strong generalization and adaptability across diverse prediction tasks,
including solubility, selectivity, toxicity, permeability, and enzyme
inhibition. While the purpose of the paper was to focus on property
prediction for mGlu2 and mGlu3 ligands, future investigation is needed
to apply I-GAT to additional data sets, particularly for properties
that are priorities for lead optimization.</p>
<p>When considering
the strong predictive performance of our approach
across multiple data sets, one perspective should be considered. Given
that our results were generated using ligands with similar receptors,
our model may demonstrate even greater predictive power when applied
to data sets containing more structurally diverse ligands. The application
of our approach is not limited to group II metabotropic glutamate
receptor ligands. Further testing with additional ligand data sets
and target properties would be highly beneficial. Not only would this
help assess the generalizability of the model, but it could also assist
researchers in identifying specific molecular regions for optimization.
Furthermore, interdisciplinary collaboration could enhance this approach.
Research groups with computational expertise but limited biological
validation capacity, and vice versa, could share insights to maximize
research impact.</p>
<p>While in vitro validation remains a crucial
next step to fully
substantiate our findings, future improvements from a computational
perspective could involve incorporating additional input features
and refining the model architecture. Specifically, integrating mesh
graph architecture with multilayer perceptron models while maintaining
multioutput prediction capability could enhance predictive accuracy.
Moreover, the model’s adaptability could be tested by training
on more diverse data sets. If various ligand classes are incorporated,
transfer learning techniques could be leveraged to extract shared
insights across different chemical spaces. Finally, the inclusion
of additional chemical properties would enable a more comprehensive
multitask learning approach, further strengthening model robustness
across diverse drug discovery applications. While we explored other
relevant data sets, we anticipate that properties such as chemical
absorption, distribution, metabolism, excretion, and toxicity (ADMET)
values can also be predicted and optimized with our approach.</p></section><section id="sec5"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>In this work, we developed
a tiered multifunction model that can
perform three tasks: 1) predict compound selectivity for mGlu2 and/or
mGlu3; 2) estimate IC50 values, and 3) classify compounds as high-potency
or low-potency ligands. Transfer learning was used to transmit the
lessons learned from the selectivity tasks to inform downstream potency
tasks in a sequential manner. We further developed a visualization
approach to highlight “problem areas” within molecules,
which is a novel strategy to facilitate the optimization of the selectivity
and/or potency of the existing ligands. We demonstrated the utility
of our strategy by designing a novel mGlu2 ligand and evaluating its
selectivity and potency using our trained model. We used mGlu2/mGlu3
as an example to develop our approach. However, our approach can be
applied to other ligand data sets and other chemical properties beyond
potency and selectivity. With more data points and higher data volume,
multiple properties could be assessed simultaneously and further scrutinized
through gradient evaluation to optimize the drug candidates. Our work
lays the foundation for artificially intelligent redesign of existing
ligands into ones with potentially superior properties. Once validated
in vitro, the successful implementation of this paradigm could lead
to the development of precise therapeutics for various use cases.</p></section><section id="sec23"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="sifile1"><div class="media p"><div class="caption">
<a href="/articles/instance/12332587/bin/ao5c02173_si_001.pdf" data-ga-action="click_feat_suppl" class="usa-link">ao5c02173_si_001.pdf</a><sup> (1.6MB, pdf) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Glossary</h2>
<h3>Abbreviations</h3>
<dl class="def-list" id="dl1">
<dt>GPCRs</dt>
<dd><p>G-protein-coupled
receptors</p></dd>
<dt>FDA</dt>
<dd><p>Food
and Drug Administration</p></dd>
<dt>mGlu2</dt>
<dd><p>metabotropic
glutamate receptor subtype 2</p></dd>
<dt>mGlu3</dt>
<dd><p>metabotropic glutamate receptor subtype 3</p></dd>
<dt>NAMs</dt>
<dd><p>negative allosteric modulators</p></dd>
<dt>I-GAT</dt>
<dd><p>Interpretable
Graph Attention Networks</p></dd>
<dt>ML</dt>
<dd><p>machine learning</p></dd>
<dt>AI</dt>
<dd><p>artificial intelligence</p></dd>
<dt>GNNs</dt>
<dd><p>Graph Neural Networks</p></dd>
<dt>XGBoost</dt>
<dd><p>eXtreme Gradient Boosting</p></dd>
<dt>SVM</dt>
<dd><p>support vector machine</p></dd>
<dt>GAT</dt>
<dd><p>Graph Attention
Networks</p></dd>
<dt>GCN</dt>
<dd><p>Graph
Convolutional Network</p></dd>
<dt>LIME</dt>
<dd><p>Local Interpretable Model-Agnostic Explanations</p></dd>
<dt>Grad-CAM</dt>
<dd><p>Gradient-Weighted
Class Activation Mapping</p></dd>
<dt>CNNs</dt>
<dd><p>Convolutional Neural Networks</p></dd>
<dt>SMILES</dt>
<dd><p>Simplified Molecular Input Line Entry System</p></dd>
<dt>RMSE</dt>
<dd><p>Root Mean Squared
Error</p></dd>
<dt>BBBP</dt>
<dd><p>Blood-Brain
Barrier Penetration</p></dd>
<dt>BACE</dt>
<dd><p>β-secretase enzyme</p></dd>
<dt>HIV</dt>
<dd><p>Human Immunodeficiency Virus</p></dd>
<dt>ClinTox</dt>
<dd><p>Clinical Toxicity</p></dd>
<dt>MAPE</dt>
<dd><p>mean absolute percentage error</p></dd>
<dt>MLP</dt>
<dd><p>multilayer perceptron</p></dd>
<dt>ADMET</dt>
<dd><p>absorption, distribution,
metabolism, excretion, and toxicity</p></dd>
</dl></section><section id="notes3"><p>The data used
for this work are included in the Supporting Information: compiled
data set. The code used to generate the composite models is available
from the GitHub repository: <a href="https://github.com/EzekMathew/MultiFunction-CHEML_GAT" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/EzekMathew/MultiFunction-CHEML_GAT</a>.</p></section><section id="notes1"><p>The Supporting
Information is
available free of charge at <a href="https://pubs.acs.org/doi/10.1021/acsomega.5c02173?goto=supporting-info" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubs.acs.org/doi/10.1021/acsomega.5c02173</a>.</p>
<ul id="silist1" class="list" style="list-style-type:none"><li><p>Figure S1: IC50 distribution of the <em>n</em> = 351 mGlu2 and <em>n</em> = 309 mGlu3 ligands derived from
patent database; Figure S2: training and validation loss curves for
the independent validation set; Table S1: selectivity accuracy summaries
for five folds, along with the values for the independent validation
set; Table S2: classification report for the selectivity model for
the 5-fold cross-validation data set; Table S3: classification report
for the selectivity model for the independent validation data set;
Figure S3: training and validation loss curves for the independent
validation set for the potency regression task; Table S4: comparison
of MAPE between models; Figure S4: potency regression output of the
GAT model; Table S5: Pearson’s correlation examination of target
arrays; Table S6: potency accuracy summaries for five folds along
with the values for the independent validation set; Table S7: potency
classification report for the dual potency and selectivity-informed
model, pertaining to the 5-fold cross-validation data set; Table S8:
potency classification report for the dual potency and selectivity-informed
model, pertaining to the independent validation data set; Table S9:
cumulative evaluation of selectivity output nodes for all available
ligands; Table S10: cumulative evaluation of potency output nodes
for all available ligands; Figure S5: selectivity optimization for
the ligand BOTH114; Figure S6: potency optimization for the ligand
A026; Figure S7: potency optimization for the ligand Be53; Figure
S8: potency optimization for the ligand BEM21; Figure S9: selectivity
analysis for the ligand A041 in triplicate; Figure S10: potency analysis
for the ligand A041 in triplicate; Figure S11: training and validation
loss curves confirm that severe overfitting did not occur over the
course of 400 epochs for the independent validation set; Figure S12:
training and validation loss curves confirm that severe overfitting
did occur over the course of 400 epochs for the independent validation
set when freezing was not incorporated; Table S11: optimal training
hyperparameters identified by Optuna for each data set; Table S12:
nitrile-containing mGlu2 compounds; Table S13: patent-derived data
set of compounds (<a href="https://pubs.acs.org/doi/suppl/10.1021/acsomega.5c02173/suppl_file/ao5c02173_si_001.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PDF</a>)</p></li></ul></section><section id="notes2"><p>The manuscript
was written through the contributions of all authors. All authors
have given approval to the final version of the manuscript.</p></section><section id="notes4"><p>This work is
partially supported by a grant (#RP210046) from the Cancer Prevention
and Research Institute of Texas (CPRIT).</p></section><section id="notes5"><p>The authors
declare the following competing financial interest(s): J.L. is a co-founder
of Neoclease, Inc.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="ref1">
<cite>Okashah N., Wan Q., Ghosh S., Sandhu M., Inoue A., Vaidehi N., Lambert N. A.. Variable G protein determinants of GPCR coupling selectivity. Proc. Natl. Acad. Sci. U. S. A. 2019;116(24):12054–12059. doi: 10.1073/pnas.1905993116.</cite> [<a href="https://doi.org/10.1073/pnas.1905993116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6575158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31142646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.%20S.%20A.&amp;title=Variable%20G%20protein%20determinants%20of%20GPCR%20coupling%20selectivity&amp;author=N.%20Okashah&amp;author=Q.%20Wan&amp;author=S.%20Ghosh&amp;author=M.%20Sandhu&amp;author=A.%20Inoue&amp;volume=116&amp;issue=24&amp;publication_year=2019&amp;pages=12054-12059&amp;pmid=31142646&amp;doi=10.1073/pnas.1905993116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref2">
<cite>Hauser A. S., Avet C., Normand C., Mancini A., Inoue A., Bouvier M., Gloriam D. E.. Common
coupling map advances GPCR-G
protein selectivity. Elife. 2022;11:74107. doi: 10.7554/eLife.74107.</cite> [<a href="https://doi.org/10.7554/eLife.74107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9005189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35302494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Common%20coupling%20map%20advances%20GPCR-G%20protein%20selectivity&amp;author=A.%20S.%20Hauser&amp;author=C.%20Avet&amp;author=C.%20Normand&amp;author=A.%20Mancini&amp;author=A.%20Inoue&amp;volume=11&amp;publication_year=2022&amp;pages=74107&amp;pmid=35302494&amp;doi=10.7554/eLife.74107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref3">
<cite>Flock T., Hauser A. S., Lund N., Gloriam D. E., Balaji S., Babu M. M.. Selectivity determinants
of GPCR-G-protein binding. Nature. 2017;545(7654):317–322. doi: 10.1038/nature22070.</cite> [<a href="https://doi.org/10.1038/nature22070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5846738/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28489817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Selectivity%20determinants%20of%20GPCR-G-protein%20binding&amp;author=T.%20Flock&amp;author=A.%20S.%20Hauser&amp;author=N.%20Lund&amp;author=D.%20E.%20Gloriam&amp;author=S.%20Balaji&amp;volume=545&amp;issue=7654&amp;publication_year=2017&amp;pages=317-322&amp;pmid=28489817&amp;doi=10.1038/nature22070&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref4">
<cite>Mattedi G., Deflorian F., Mason J. S., de Graaf C., Gervasio F. L.. Understanding
Ligand Binding Selectivity in a Prototypical GPCR Family. J. Chem. Inf. Model. 2019;59(6):2830–2836. doi: 10.1021/acs.jcim.9b00298.</cite> [<a href="https://doi.org/10.1021/acs.jcim.9b00298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7007187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31125224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Inf.%20Model.&amp;title=Understanding%20Ligand%20Binding%20Selectivity%20in%20a%20Prototypical%20GPCR%20Family&amp;author=G.%20Mattedi&amp;author=F.%20Deflorian&amp;author=J.%20S.%20Mason&amp;author=C.%20de%20Graaf&amp;author=F.%20L.%20Gervasio&amp;volume=59&amp;issue=6&amp;publication_year=2019&amp;pages=2830-2836&amp;pmid=31125224&amp;doi=10.1021/acs.jcim.9b00298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref5">
<cite>Hauser A. S., Attwood M. M., Rask-Andersen M., Schioth H. B., Gloriam D. E.. Trends
in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discovery. 2017;16(12):829–842. doi: 10.1038/nrd.2017.178.</cite> [<a href="https://doi.org/10.1038/nrd.2017.178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6882681/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29075003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Drug%20Discovery&amp;title=Trends%20in%20GPCR%20drug%20discovery:%20new%20agents,%20targets%20and%20indications&amp;author=A.%20S.%20Hauser&amp;author=M.%20M.%20Attwood&amp;author=M.%20Rask-Andersen&amp;author=H.%20B.%20Schioth&amp;author=D.%20E.%20Gloriam&amp;volume=16&amp;issue=12&amp;publication_year=2017&amp;pages=829-842&amp;pmid=29075003&amp;doi=10.1038/nrd.2017.178&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref6">
<cite>Sriram K., Insel P. A.. G Protein-Coupled
Receptors as Targets for Approved
Drugs: How Many Targets and How Many Drugs? Mol. Pharmacol. 2018;93(4):251–258. doi: 10.1124/mol.117.111062.</cite> [<a href="https://doi.org/10.1124/mol.117.111062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5820538/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29298813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmacol.&amp;title=G%20Protein-Coupled%20Receptors%20as%20Targets%20for%20Approved%20Drugs:%20How%20Many%20Targets%20and%20How%20Many%20Drugs?&amp;author=K.%20Sriram&amp;author=P.%20A.%20Insel&amp;volume=93&amp;issue=4&amp;publication_year=2018&amp;pages=251-258&amp;pmid=29298813&amp;doi=10.1124/mol.117.111062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref7">
<cite>Tan L., Yan W., McCorvy J. D., Cheng J.. Biased Ligands of G Protein-Coupled
Receptors (GPCRs): Structure-Functional Selectivity Relationships
(SFSRs) and Therapeutic Potential. J. Med. Chem. 2018;61(22):9841–9878. doi: 10.1021/acs.jmedchem.8b00435.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.8b00435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29939744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Biased%20Ligands%20of%20G%20Protein-Coupled%20Receptors%20(GPCRs):%20Structure-Functional%20Selectivity%20Relationships%20(SFSRs)%20and%20Therapeutic%20Potential&amp;author=L.%20Tan&amp;author=W.%20Yan&amp;author=J.%20D.%20McCorvy&amp;author=J.%20Cheng&amp;volume=61&amp;issue=22&amp;publication_year=2018&amp;pages=9841-9878&amp;pmid=29939744&amp;doi=10.1021/acs.jmedchem.8b00435&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref8">
<cite>Powers A. S., Pham V., Burger W. A. C., Thompson G., Laloudakis Y., Barnes N. W., Sexton P. M., Paul S. M., Christopoulos A., Thal D. M., Felder C. C., Valant C., Dror R. O.. Structural
basis of efficacy-driven ligand selectivity at GPCRs. Nat. Chem. Biol. 2023;19(7):805–814. doi: 10.1038/s41589-022-01247-5.</cite> [<a href="https://doi.org/10.1038/s41589-022-01247-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10299909/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36782010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Chem.%20Biol.&amp;title=Structural%20basis%20of%20efficacy-driven%20ligand%20selectivity%20at%20GPCRs&amp;author=A.%20S.%20Powers&amp;author=V.%20Pham&amp;author=W.%20A.%20C.%20Burger&amp;author=G.%20Thompson&amp;author=Y.%20Laloudakis&amp;volume=19&amp;issue=7&amp;publication_year=2023&amp;pages=805-814&amp;pmid=36782010&amp;doi=10.1038/s41589-022-01247-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref9">
<cite>Corti C., Battaglia G., Molinaro G., Riozzi B., Pittaluga A., Corsi M., Mugnaini M., Nicoletti F., Bruno V.. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3
metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. J. Neurosci. 2007;27(31):8297–8308. doi: 10.1523/JNEUROSCI.1889-07.2007.</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.1889-07.2007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6673047/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17670976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurosci.&amp;title=The%20use%20of%20knock-out%20mice%20unravels%20distinct%20roles%20for%20mGlu2%20and%20mGlu3%20metabotropic%20glutamate%20receptors%20in%20mechanisms%20of%20neurodegeneration/neuroprotection&amp;author=C.%20Corti&amp;author=G.%20Battaglia&amp;author=G.%20Molinaro&amp;author=B.%20Riozzi&amp;author=A.%20Pittaluga&amp;volume=27&amp;issue=31&amp;publication_year=2007&amp;pages=8297-8308&amp;pmid=17670976&amp;doi=10.1523/JNEUROSCI.1889-07.2007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref10">
<cite>Mastroiacovo F., Moyanova S., Cannella M., Gaglione A., Verhaeghe R., Bozza G., Madonna M., Motolese M., Traficante A., Riozzi B.. et al. Genetic
deletion of mGlu2 metabotropic glutamate receptors
improves the short-term outcome of cerebral transient focal ischemia. Mol. Brain. 2017;10(1):39. doi: 10.1186/s13041-017-0319-6.</cite> [<a href="https://doi.org/10.1186/s13041-017-0319-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5562974/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28821279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Brain&amp;title=Genetic%20deletion%20of%20mGlu2%20metabotropic%20glutamate%20receptors%20improves%20the%20short-term%20outcome%20of%20cerebral%20transient%20focal%20ischemia&amp;author=F.%20Mastroiacovo&amp;author=S.%20Moyanova&amp;author=M.%20Cannella&amp;author=A.%20Gaglione&amp;author=R.%20Verhaeghe&amp;volume=10&amp;issue=1&amp;publication_year=2017&amp;pages=39&amp;pmid=28821279&amp;doi=10.1186/s13041-017-0319-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref11">
<cite>Durand D., Carniglia L., Beauquis J., Caruso C., Saravia F., Lasaga M.. Astroglial
mGlu3 receptors promote alpha-secretase-mediated
amyloid precursor protein cleavage. Neuropharmacology. 2014;79:180–189. doi: 10.1016/j.neuropharm.2013.11.015.</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2013.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24291464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Astroglial%20mGlu3%20receptors%20promote%20alpha-secretase-mediated%20amyloid%20precursor%20protein%20cleavage&amp;author=D.%20Durand&amp;author=L.%20Carniglia&amp;author=J.%20Beauquis&amp;author=C.%20Caruso&amp;author=F.%20Saravia&amp;volume=79&amp;publication_year=2014&amp;pages=180-189&amp;pmid=24291464&amp;doi=10.1016/j.neuropharm.2013.11.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref12">
<cite>Turati J., Ramirez D., Carniglia L., Saba J., Caruso C., Quarleri J., Durand D., Lasaga M.. Antioxidant and neuroprotective
effects of mGlu3 receptor activation on astrocytes aged in vitro. Neurochem. Int. 2020;140:104837. doi: 10.1016/j.neuint.2020.104837.</cite> [<a href="https://doi.org/10.1016/j.neuint.2020.104837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32858088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurochem.%20Int.&amp;title=Antioxidant%20and%20neuroprotective%20effects%20of%20mGlu3%20receptor%20activation%20on%20astrocytes%20aged%20in%20vitro&amp;author=J.%20Turati&amp;author=D.%20Ramirez&amp;author=L.%20Carniglia&amp;author=J.%20Saba&amp;author=C.%20Caruso&amp;volume=140&amp;publication_year=2020&amp;pages=104837&amp;pmid=32858088&amp;doi=10.1016/j.neuint.2020.104837&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref13">
<cite>Durand D., Carniglia L., Caruso C., Lasaga. M., mGlu3 receptor and astrocytes:
partners in neuroprotection. Neuropharmacology. 2013;66:1–11. doi: 10.1016/j.neuropharm.2012.04.009.</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2012.04.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22564439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=M.,%20mGlu3%20receptor%20and%20astrocytes:%20partners%20in%20neuroprotection&amp;author=D.%20Durand&amp;author=L.%20Carniglia&amp;author=C.%20Caruso&amp;author=%20Lasaga&amp;volume=66&amp;publication_year=2013&amp;pages=1-11&amp;pmid=22564439&amp;doi=10.1016/j.neuropharm.2012.04.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref14">
<cite>Caraci F., Battaglia G., Sortino M. A., Spampinato S., Molinaro G., Copani A., Nicoletti F., Bruno V.. Metabotropic glutamate receptors
in neurodegeneration/neuroprotection:
still a hot topic? Neurochem. Int. 2012;61(4):559–565. doi: 10.1016/j.neuint.2012.01.017.</cite> [<a href="https://doi.org/10.1016/j.neuint.2012.01.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22306345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurochem.%20Int.&amp;title=Metabotropic%20glutamate%20receptors%20in%20neurodegeneration/neuroprotection:%20still%20a%20hot%20topic?&amp;author=F.%20Caraci&amp;author=G.%20Battaglia&amp;author=M.%20A.%20Sortino&amp;author=S.%20Spampinato&amp;author=G.%20Molinaro&amp;volume=61&amp;issue=4&amp;publication_year=2012&amp;pages=559-565&amp;pmid=22306345&amp;doi=10.1016/j.neuint.2012.01.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref15">
<cite>Caraci F., Molinaro G., Battaglia G., Giuffrida M. L., Riozzi B., Traficante A., Bruno V., Cannella M., Merlo S., Wang X., Heinz B. A., Nisenbaum E. S., Britton T. C., Drago F., Sortino M. A., Copani A., Nicoletti F.. Targeting
group II metabotropic glutamate (mGlu) receptors
for the treatment of psychosis associated with Alzheimer’s
disease: selective activation of mGlu2 receptors amplifies beta-amyloid
toxicity in cultured neurons, whereas dual activation of mGlu2 and
mGlu3 receptors is neuroprotective. Mol. Pharmacol. 2011;79(3):618–626. doi: 10.1124/mol.110.067488.</cite> [<a href="https://doi.org/10.1124/mol.110.067488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21159998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmacol.&amp;title=Targeting%20group%20II%20metabotropic%20glutamate%20(mGlu)%20receptors%20for%20the%20treatment%20of%20psychosis%20associated%20with%20Alzheimer%E2%80%99s%20disease:%20selective%20activation%20of%20mGlu2%20receptors%20amplifies%20beta-amyloid%20toxicity%20in%20cultured%20neurons,%20whereas%20dual%20activation%20of%20mGlu2%20and%20mGlu3%20receptors%20is%20neuroprotective&amp;author=F.%20Caraci&amp;author=G.%20Molinaro&amp;author=G.%20Battaglia&amp;author=M.%20L.%20Giuffrida&amp;author=B.%20Riozzi&amp;volume=79&amp;issue=3&amp;publication_year=2011&amp;pages=618-626&amp;pmid=21159998&amp;doi=10.1124/mol.110.067488&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref16">
<cite>O’Brien D. E., Shaw D. M., Cho H. P., Cross A. J., Wesolowski S. S., Felts A. S., Bergare J., Elmore C. S., Lindsley C. W., Niswender C. M., Conn P. J.. Differential Pharmacology and Binding
of mGlu(2) Receptor Allosteric Modulators. Mol.
Pharmacol. 2018;93(5):526–540. doi: 10.1124/mol.117.110114.</cite> [<a href="https://doi.org/10.1124/mol.117.110114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5894801/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29545267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Pharmacol.&amp;title=Differential%20Pharmacology%20and%20Binding%20of%20mGlu(2)%20Receptor%20Allosteric%20Modulators&amp;author=D.%20E.%20O%E2%80%99Brien&amp;author=D.%20M.%20Shaw&amp;author=H.%20P.%20Cho&amp;author=A.%20J.%20Cross&amp;author=S.%20S.%20Wesolowski&amp;volume=93&amp;issue=5&amp;publication_year=2018&amp;pages=526-540&amp;pmid=29545267&amp;doi=10.1124/mol.117.110114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref17">
<cite>Schoepp D. D., Jane D. E., Monn J. A.. Pharmacological agents acting at
subtypes of metabotropic glutamate receptors. Neuropharmacology. 1999;38(10):1431–1476. doi: 10.1016/S0028-3908(99)00092-1.</cite> [<a href="https://doi.org/10.1016/S0028-3908(99)00092-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10530808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology&amp;title=Pharmacological%20agents%20acting%20at%20subtypes%20of%20metabotropic%20glutamate%20receptors&amp;author=D.%20D.%20Schoepp&amp;author=D.%20E.%20Jane&amp;author=J.%20A.%20Monn&amp;volume=38&amp;issue=10&amp;publication_year=1999&amp;pages=1431-1476&amp;pmid=10530808&amp;doi=10.1016/S0028-3908(99)00092-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref18">
<cite>Yao Y., Pattabiraman N., Michne W. F., Huang X. P., Hampson D. R.. Molecular
modeling and mutagenesis of the ligand-binding pocket of the mGlu3
subtype of metabotropic glutamate receptor. J. Neurochem. 2003;86(4):947–957. doi: 10.1046/j.1471-4159.2003.01906.x.</cite> [<a href="https://doi.org/10.1046/j.1471-4159.2003.01906.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12887692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurochem.&amp;title=Molecular%20modeling%20and%20mutagenesis%20of%20the%20ligand-binding%20pocket%20of%20the%20mGlu3%20subtype%20of%20metabotropic%20glutamate%20receptor&amp;author=Y.%20Yao&amp;author=N.%20Pattabiraman&amp;author=W.%20F.%20Michne&amp;author=X.%20P.%20Huang&amp;author=D.%20R.%20Hampson&amp;volume=86&amp;issue=4&amp;publication_year=2003&amp;pages=947-957&amp;pmid=12887692&amp;doi=10.1046/j.1471-4159.2003.01906.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref19"><cite>

Bungard, C. J.
; 
Converso, A.
; 
De Leon, P.
; 
Hanney, B.
; 
Hartingh, T. J.
; 
Manikowski, J. J.
; 
Manley, P. J.
; 
Meissner, R.
; 
Meng, Z.
; 
Perkins, J. J.
, et al. 
Quinoline Carboxamide
and Quinoline Carbonitrile Derivatives as mGlur2-Negative Allosteric
Modulators, Compositions, and Their Use, WO 2,013,066,736 A1, 2013.</cite></li>
<li id="ref20">
<cite>Felts A. S., Rodriguez A. L., Smith K. A., Engers J. L., Morrison R. D., Byers F. W., Blobaum A. L., Locuson C. W., Chang S., Venable D. F., Niswender C. M., Daniels J. S., Conn P. J., Lindsley C. W., Emmitte K. A.. Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides
as Selective Negative Allosteric Modulators of Metabotropic Glutamate
Receptor Subtype 2. J. Med. Chem. 2015;58(22):9027–9040. doi: 10.1021/acs.jmedchem.5b01371.</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.5b01371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4817271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26524606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Design%20of%204-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides%20as%20Selective%20Negative%20Allosteric%20Modulators%20of%20Metabotropic%20Glutamate%20Receptor%20Subtype%202&amp;author=A.%20S.%20Felts&amp;author=A.%20L.%20Rodriguez&amp;author=K.%20A.%20Smith&amp;author=J.%20L.%20Engers&amp;author=R.%20D.%20Morrison&amp;volume=58&amp;issue=22&amp;publication_year=2015&amp;pages=9027-9040&amp;pmid=26524606&amp;doi=10.1021/acs.jmedchem.5b01371&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref21">
<cite>Wenthur C. J., Morrison R., Felts A. S., Smith K. A., Engers J. L., Byers F. W., Daniels J. S., Emmitte K. A., Conn P. J., Lindsley C. W.. Discovery of (R)-(2-fluoro-4-((−4-methoxyphenyl)­ethynyl)­phenyl)
(3-hydroxypiperidin-1-yl)­methanone (ML337), an mGlu3 selective and
CNS penetrant negative allosteric modulator (NAM) J. Med. Chem. 2013;56(12):5208–5212. doi: 10.1021/jm400439t.</cite> [<a href="https://doi.org/10.1021/jm400439t" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3769689/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23718281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Chem.&amp;title=Discovery%20of%20(R)-(2-fluoro-4-((%E2%88%924-methoxyphenyl)%C2%ADethynyl)%C2%ADphenyl)%20(3-hydroxypiperidin-1-yl)%C2%ADmethanone%20(ML337),%20an%20mGlu3%20selective%20and%20CNS%20penetrant%20negative%20allosteric%20modulator%20(NAM)&amp;author=C.%20J.%20Wenthur&amp;author=R.%20Morrison&amp;author=A.%20S.%20Felts&amp;author=K.%20A.%20Smith&amp;author=J.%20L.%20Engers&amp;volume=56&amp;issue=12&amp;publication_year=2013&amp;pages=5208-5212&amp;pmid=23718281&amp;doi=10.1021/jm400439t&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref22"><cite>

Conn, P. J.
; 
Lindsley, C. W.
; 
Emmitte, K. A.
; 
Engers, J. L.
; 
Konkol, L. C.
. 
Substituted pyrazolo[1,5-a]pyrazines
as negative allosteric modulators of metabotropic glutamate receptor
3, US 9,676,782 B2, 2015.</cite></li>
<li id="ref23">
<cite>Engers J. L., Bollinger K. A., Weiner R. L., Rodriguez A. L., Long M. F., Breiner M. M., Chang S., Bollinger S. R., Bubser M., Jones C. K., Morrison R. D., Bridges T. M., Blobaum A. L., Niswender C. M., Conn P. J., Emmitte K. A., Lindsley C. W.. Design and Synthesis of N-Aryl Phenoxyethoxy Pyridinones
as Highly Selective and CNS Penetrant mGlu(3) NAMs. ACS Med. Chem. Lett. 2017;8(9):925–930. doi: 10.1021/acsmedchemlett.7b00249.</cite> [<a href="https://doi.org/10.1021/acsmedchemlett.7b00249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5601378/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28947938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med.%20Chem.%20Lett.&amp;title=Design%20and%20Synthesis%20of%20N-Aryl%20Phenoxyethoxy%20Pyridinones%20as%20Highly%20Selective%20and%20CNS%20Penetrant%20mGlu(3)%20NAMs&amp;author=J.%20L.%20Engers&amp;author=K.%20A.%20Bollinger&amp;author=R.%20L.%20Weiner&amp;author=A.%20L.%20Rodriguez&amp;author=M.%20F.%20Long&amp;volume=8&amp;issue=9&amp;publication_year=2017&amp;pages=925-930&amp;pmid=28947938&amp;doi=10.1021/acsmedchemlett.7b00249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref24"><cite>

Conn, P. J.
; 
Lindsley, C. W.
; 
Emmitte, K. A.
; 
Engers, J. L.
; 
Bollinger, K. A.
; 
Breiner, M. M.
, Negative allosteric
modulators of metabotropic glutamate receptor 3. 2016, WO 2,016,130,652 A1.</cite></li>
<li id="ref25">
<cite>

Scarselli, F.
; 
Gori, M.
; 
Tsoi, A. C.
; 
Hagenbuchner, M.
; 
Monfardini, G.
. 
The Graph Neural Network Model
Transactions On Neural Networks
IEEE; 
2009. 
20
1
61–80

</cite> [<a href="https://doi.org/10.1109/TNN.2008.2005605" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19068426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Transactions%20On%20Neural%20Networks&amp;publication_year=2009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref26">
<cite>

Gori, M.
; 
Monfardini, G.
; 
Scarselli, F.
. 
In A new model
for learning in graph domains
International
Joint Conference On Neural Networks
IEEE; 
2005. 
2
729–734
</cite> [<a href="https://scholar.google.com/scholar_lookup?title=International%20Joint%20Conference%20On%20Neural%20Networks&amp;publication_year=2005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref27">
<cite>

Gao, C.
; 
Yin, S.
; 
Wang, H.
; 
Wang, Z.
; 
Du, Z.
; 
Li, X.
. 
Medical-Knowledge-Based Graph Neural Network for Medication Combination
Prediction
IEEE Transactions on Neural Networks
and Learning Systems
IEEE; 
2024. 
35
10
13246–13257
10.1109/TNNLS.2023.3266490

</cite> [<a href="https://doi.org/10.1109/TNNLS.2023.3266490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37141055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=IEEE%20Transactions%20on%20Neural%20Networks%20and%20Learning%20Systems&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref28">
<cite>Bessadok A., Mahjoub M. A., Rekik I.. Graph Neural
Networks in Network
Neuroscience. IEEE Trans. Pattern Anal. Mach.
Intell. 2023;45(5):5833–5848. doi: 10.1109/TPAMI.2022.3209686.</cite> [<a href="https://doi.org/10.1109/TPAMI.2022.3209686" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36155474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IEEE%20Trans.%20Pattern%20Anal.%20Mach.%20Intell.&amp;title=Graph%20Neural%20Networks%20in%20Network%20Neuroscience&amp;author=A.%20Bessadok&amp;author=M.%20A.%20Mahjoub&amp;author=I.%20Rekik&amp;volume=45&amp;issue=5&amp;publication_year=2023&amp;pages=5833-5848&amp;pmid=36155474&amp;doi=10.1109/TPAMI.2022.3209686&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref29">
<cite>Cui H., Wang X., Zhou J., Eberl S., Yin Y., Feng D., Fulham M.. Topology polymorphism graph for lung
tumor segmentation in PET-CT images. Phys. Med.
Biol. 2015;60(12):4893–4914. doi: 10.1088/0031-9155/60/12/4893.</cite> [<a href="https://doi.org/10.1088/0031-9155/60/12/4893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26056866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys.%20Med.%20Biol.&amp;title=Topology%20polymorphism%20graph%20for%20lung%20tumor%20segmentation%20in%20PET-CT%20images&amp;author=H.%20Cui&amp;author=X.%20Wang&amp;author=J.%20Zhou&amp;author=S.%20Eberl&amp;author=Y.%20Yin&amp;volume=60&amp;issue=12&amp;publication_year=2015&amp;pages=4893-4914&amp;pmid=26056866&amp;doi=10.1088/0031-9155/60/12/4893&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref30">
<cite>Jiang D., Wu Z., Hsieh C.-Y., Chen G., Liao B., Wang Z., Shen C., Cao D., Wu J., Hou T.. Could graph
neural networks learn better molecular representation for drug discovery?
A comparison study of descriptor-based and graph-based models. J. Cheminf. 2021;13(1):12. doi: 10.1186/s13321-020-00479-8.</cite> [<a href="https://doi.org/10.1186/s13321-020-00479-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7888189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33597034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cheminf.&amp;title=Could%20graph%20neural%20networks%20learn%20better%20molecular%20representation%20for%20drug%20discovery?%20A%20comparison%20study%20of%20descriptor-based%20and%20graph-based%20models&amp;author=D.%20Jiang&amp;author=Z.%20Wu&amp;author=C.-Y.%20Hsieh&amp;author=G.%20Chen&amp;author=B.%20Liao&amp;volume=13&amp;issue=1&amp;publication_year=2021&amp;pages=12&amp;pmid=33597034&amp;doi=10.1186/s13321-020-00479-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref31">
<cite>Cremer J., Sandonas L. M., Tkatchenko A., Clevert D.-A., De Fabritiis G.. Equivariant
Graph Neural Networks for Toxicity Prediction. Chem. Res. Toxicol. 2023;36(10):1561–1573. doi: 10.1021/acs.chemrestox.3c00032.</cite> [<a href="https://doi.org/10.1021/acs.chemrestox.3c00032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10583285/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37690056/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem.%20Res.%20Toxicol.&amp;title=Equivariant%20Graph%20Neural%20Networks%20for%20Toxicity%20Prediction&amp;author=J.%20Cremer&amp;author=L.%20M.%20Sandonas&amp;author=A.%20Tkatchenko&amp;author=D.-A.%20Clevert&amp;author=G.%20De%20Fabritiis&amp;volume=36&amp;issue=10&amp;publication_year=2023&amp;pages=1561-1573&amp;pmid=37690056&amp;doi=10.1021/acs.chemrestox.3c00032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref32">
<cite>Chen J., Si Y. W., Un C. W., Siu S. W. I.. Chemical toxicity
prediction based on semi-supervised learning and graph convolutional
neural network. J. Cheminf. 2021;13(1):93. doi: 10.1186/s13321-021-00570-8.</cite> [<a href="https://doi.org/10.1186/s13321-021-00570-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8627024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34838140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cheminf.&amp;title=Chemical%20toxicity%20prediction%20based%20on%20semi-supervised%20learning%20and%20graph%20convolutional%20neural%20network&amp;author=J.%20Chen&amp;author=Y.%20W.%20Si&amp;author=C.%20W.%20Un&amp;author=S.%20W.%20I.%20Siu&amp;volume=13&amp;issue=1&amp;publication_year=2021&amp;pages=93&amp;pmid=34838140&amp;doi=10.1186/s13321-021-00570-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref33">
<cite>Hasebe T.. Knowledge-Embedded
Message-Passing Neural Networks: Improving Molecular Property Prediction
with Human Knowledge. ACS Omega. 2021;6(42):27955–27967. doi: 10.1021/acsomega.1c03839.</cite> [<a href="https://doi.org/10.1021/acsomega.1c03839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8552328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34722995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Knowledge-Embedded%20Message-Passing%20Neural%20Networks:%20Improving%20Molecular%20Property%20Prediction%20with%20Human%20Knowledge&amp;author=T.%20Hasebe&amp;volume=6&amp;issue=42&amp;publication_year=2021&amp;pages=27955-27967&amp;pmid=34722995&amp;doi=10.1021/acsomega.1c03839&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref34">
<cite>Ahmad W., Tayara H., Chong K. T.. Attention-Based Graph Neural Network
for Molecular Solubility Prediction. ACS Omega. 2023;8(3):3236–3244. doi: 10.1021/acsomega.2c06702.</cite> [<a href="https://doi.org/10.1021/acsomega.2c06702" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9878542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36713733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Omega&amp;title=Attention-Based%20Graph%20Neural%20Network%20for%20Molecular%20Solubility%20Prediction&amp;author=W.%20Ahmad&amp;author=H.%20Tayara&amp;author=K.%20T.%20Chong&amp;volume=8&amp;issue=3&amp;publication_year=2023&amp;pages=3236-3244&amp;pmid=36713733&amp;doi=10.1021/acsomega.2c06702&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref35">
<cite>Kengkanna A., Ohue M.. Enhancing property and activity prediction and interpretation using
multiple molecular graph representations with MMGX. Commun. Chem. 2024;7(1):74. doi: 10.1038/s42004-024-01155-w.</cite> [<a href="https://doi.org/10.1038/s42004-024-01155-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10997661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38580841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun.%20Chem.&amp;title=Enhancing%20property%20and%20activity%20prediction%20and%20interpretation%20using%20multiple%20molecular%20graph%20representations%20with%20MMGX&amp;author=A.%20Kengkanna&amp;author=M.%20Ohue&amp;volume=7&amp;issue=1&amp;publication_year=2024&amp;pages=74&amp;pmid=38580841&amp;doi=10.1038/s42004-024-01155-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref36">
<cite>Tsubaki M., Tomii K., Sese J.. Compound-protein
interaction prediction
with end-to-end learning of neural networks for graphs and sequences. Bioinformatics. 2019;35(2):309–318. doi: 10.1093/bioinformatics/bty535.</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29982330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Compound-protein%20interaction%20prediction%20with%20end-to-end%20learning%20of%20neural%20networks%20for%20graphs%20and%20sequences&amp;author=M.%20Tsubaki&amp;author=K.%20Tomii&amp;author=J.%20Sese&amp;volume=35&amp;issue=2&amp;publication_year=2019&amp;pages=309-318&amp;pmid=29982330&amp;doi=10.1093/bioinformatics/bty535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref37">
<cite>

Ying, R.
; 
Bourgeois, D.
; 
You, J.
; 
Zitnik, M.
; 
Leskovec, J.
. 
GNNExplainer:
Generating Explanations
for Graph Neural Networks. arXiv: 1903.03894 Accessed 01, March 2019. 2019.</cite> [<a href="/articles/PMC7138248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32265580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=arXiv:%201903.03894&amp;title=GNNExplainer:%20Generating%20Explanations%20for%20Graph%20Neural%20Networks&amp;publication_year=2019&amp;pmid=32265580&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref38">
<cite>

Kasanishi, T.
; 
Wang, X.
; 
Yamasaki, T.
. 
Edge-Level Explanations for
Graph Neural Networks by Extending Explainability Methods for Convolutional
Neural Networks 2021. arXiv: 2111.00722 Accessed 01, November 2021.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=arXiv:%202111.00722&amp;title=Edge-Level%20Explanations%20for%20Graph%20Neural%20Networks%20by%20Extending%20Explainability%20Methods%20for%20Convolutional%20Neural%20Networks%202021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref39">
<cite>Kotobi A., Singh K., Hoche D., Bari S., Meissner R. H., Bande A.. Integrating Explainability into Graph Neural Network Models for the
Prediction of X-ray Absorption Spectra. J. Am.
Chem. Soc. 2023;145(41):22584–22598. doi: 10.1021/jacs.3c07513.</cite> [<a href="https://doi.org/10.1021/jacs.3c07513" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10591337/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37807700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Chem.%20Soc.&amp;title=Integrating%20Explainability%20into%20Graph%20Neural%20Network%20Models%20for%20the%20Prediction%20of%20X-ray%20Absorption%20Spectra&amp;author=A.%20Kotobi&amp;author=K.%20Singh&amp;author=D.%20Hoche&amp;author=S.%20Bari&amp;author=R.%20H.%20Meissner&amp;volume=145&amp;issue=41&amp;publication_year=2023&amp;pages=22584-22598&amp;pmid=37807700&amp;doi=10.1021/jacs.3c07513&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref40">
<cite>Kensert A., Bouwmeester R., Efthymiadis K., Van Broeck P., Desmet G., Cabooter D.. Graph Convolutional Networks for
Improved Prediction and Interpretability of Chromatographic Retention
Data. Anal. Chem. 2021;93(47):15633–15641. doi: 10.1021/acs.analchem.1c02988.</cite> [<a href="https://doi.org/10.1021/acs.analchem.1c02988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34780168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anal.%20Chem.&amp;title=Graph%20Convolutional%20Networks%20for%20Improved%20Prediction%20and%20Interpretability%20of%20Chromatographic%20Retention%20Data&amp;author=A.%20Kensert&amp;author=R.%20Bouwmeester&amp;author=K.%20Efthymiadis&amp;author=P.%20Van%20Broeck&amp;author=G.%20Desmet&amp;volume=93&amp;issue=47&amp;publication_year=2021&amp;pages=15633-15641&amp;pmid=34780168&amp;doi=10.1021/acs.analchem.1c02988&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref41">
<cite>Weber J. K., Morrone J. A., Bagchi S., Pabon J. D. E., Kang S. G., Zhang L., Cornell W. D.. Simplified,
interpretable graph convolutional
neural networks for small molecule activity prediction. J. comput.-Aided Mol. Des. 2022;36(5):391–404. doi: 10.1007/s10822-021-00421-6.</cite> [<a href="https://doi.org/10.1007/s10822-021-00421-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9325818/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34817762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20comput.-Aided%20Mol.%20Des.&amp;title=Simplified,%20interpretable%20graph%20convolutional%20neural%20networks%20for%20small%20molecule%20activity%20prediction&amp;author=J.%20K.%20Weber&amp;author=J.%20A.%20Morrone&amp;author=S.%20Bagchi&amp;author=J.%20D.%20E.%20Pabon&amp;author=S.%20G.%20Kang&amp;volume=36&amp;issue=5&amp;publication_year=2022&amp;pages=391-404&amp;pmid=34817762&amp;doi=10.1007/s10822-021-00421-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref42">
<cite>Rao J., Zheng S., Lu Y., Yang Y.. Quantitative evaluation
of explainable graph neural networks for molecular property prediction. Patterns. 2022;3(12):100628. doi: 10.1016/j.patter.2022.100628.</cite> [<a href="https://doi.org/10.1016/j.patter.2022.100628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9782255/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36569553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Patterns&amp;title=Quantitative%20evaluation%20of%20explainable%20graph%20neural%20networks%20for%20molecular%20property%20prediction&amp;author=J.%20Rao&amp;author=S.%20Zheng&amp;author=Y.%20Lu&amp;author=Y.%20Yang&amp;volume=3&amp;issue=12&amp;publication_year=2022&amp;pages=100628&amp;pmid=36569553&amp;doi=10.1016/j.patter.2022.100628&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref43">
<cite>Mastropietro A., Pasculli G., Bajorath J.. Protocol to explain
graph neural
network predictions using an edge-centric Shapley value-based approach. STAR Protoc. 2022;3(4):101887. doi: 10.1016/j.xpro.2022.101887.</cite> [<a href="https://doi.org/10.1016/j.xpro.2022.101887" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9700376/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36595907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=STAR%20Protoc.&amp;title=Protocol%20to%20explain%20graph%20neural%20network%20predictions%20using%20an%20edge-centric%20Shapley%20value-based%20approach&amp;author=A.%20Mastropietro&amp;author=G.%20Pasculli&amp;author=J.%20Bajorath&amp;volume=3&amp;issue=4&amp;publication_year=2022&amp;pages=101887&amp;pmid=36595907&amp;doi=10.1016/j.xpro.2022.101887&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref44">
<cite>Wu Z., Wang J., Du H., Jiang D., Kang Y., Li D., Pan P., Deng Y., Cao D., Hsieh C.-Y., Hou T.. Chemistry-intuitive explanation of graph neural networks for molecular
property prediction with substructure masking. Nat. Commun. 2023;14(1):2585. doi: 10.1038/s41467-023-38192-3.</cite> [<a href="https://doi.org/10.1038/s41467-023-38192-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10160109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37142585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Chemistry-intuitive%20explanation%20of%20graph%20neural%20networks%20for%20molecular%20property%20prediction%20with%20substructure%20masking&amp;author=Z.%20Wu&amp;author=J.%20Wang&amp;author=H.%20Du&amp;author=D.%20Jiang&amp;author=Y.%20Kang&amp;volume=14&amp;issue=1&amp;publication_year=2023&amp;pages=2585&amp;pmid=37142585&amp;doi=10.1038/s41467-023-38192-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref45"><cite>

Cosford, N. D. J.
; 
Raveendra-Panickar, D.
; 
Sheffler, D. J.
; 
Hutchinson, J. H.
; 
Gadient, R. A.
. 
Metabotropic
Glutamate Receptor Negative Allosteric Modulators (NAMS) and Uses
Thereof, US 10,597,367 B2, 2024. 
</cite></li>
<li id="ref46">
<cite>Bienfait B., Ertl P.. JSME: a free molecule editor in JavaScript. J. Cheminf. 2013;5(1):24. doi: 10.1186/1758-2946-5-24.</cite> [<a href="https://doi.org/10.1186/1758-2946-5-24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3662632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23694746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cheminf.&amp;title=JSME:%20a%20free%20molecule%20editor%20in%20JavaScript&amp;author=B.%20Bienfait&amp;author=P.%20Ertl&amp;volume=5&amp;issue=1&amp;publication_year=2013&amp;pages=24&amp;pmid=23694746&amp;doi=10.1186/1758-2946-5-24&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref47">
<cite>Cui Q., Lu S., Ni B., Zeng X., Tan Y., Chen Y. D., Zhao H.. Improved Prediction
of Aqueous Solubility of Novel Compounds by Going
Deeper With Deep Learning. Front. Oncol. 2020;10:121. doi: 10.3389/fonc.2020.00121.</cite> [<a href="https://doi.org/10.3389/fonc.2020.00121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7026387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32117768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=Improved%20Prediction%20of%20Aqueous%20Solubility%20of%20Novel%20Compounds%20by%20Going%20Deeper%20With%20Deep%20Learning&amp;author=Q.%20Cui&amp;author=S.%20Lu&amp;author=B.%20Ni&amp;author=X.%20Zeng&amp;author=Y.%20Tan&amp;volume=10&amp;publication_year=2020&amp;pages=121&amp;pmid=32117768&amp;doi=10.3389/fonc.2020.00121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref48">
<cite>Xu Y., Liu X., Xia W., Ge J., Ju C. W., Zhang H., Zhang J. Z. H.. ChemXTree: A Feature-Enhanced Graph Neural Network-Neural
Decision Tree Framework for ADMET Prediction. J. Chem. Inf. Model. 2024;64(22):8440–8452. doi: 10.1021/acs.jcim.4c01186.</cite> [<a href="https://doi.org/10.1021/acs.jcim.4c01186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11600499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39497657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Inf.%20Model.&amp;title=ChemXTree:%20A%20Feature-Enhanced%20Graph%20Neural%20Network-Neural%20Decision%20Tree%20Framework%20for%20ADMET%20Prediction&amp;author=Y.%20Xu&amp;author=X.%20Liu&amp;author=W.%20Xia&amp;author=J.%20Ge&amp;author=C.%20W.%20Ju&amp;volume=64&amp;issue=22&amp;publication_year=2024&amp;pages=8440-8452&amp;pmid=39497657&amp;doi=10.1021/acs.jcim.4c01186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref49">
<cite>Coleman J. S., Capstick R. A., Rathnayake U. A., Parr L., Chang S., Thompson A. D., Qi A., Niswender C. M., Boutaud O., Plumley H.. et al. Development
of Potent
and Selective Negative Allosteric Modulators of the Metabotropic Glutamate
Receptor 2 for the Potential Treatment of Alzheimer’s Disease. Alzheimers Dement. 2023;19(S21):e076916.  doi: 10.1002/alz.076916.</cite> [<a href="https://doi.org/10.1002/alz.076916" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimers%20Dement.&amp;title=Development%20of%20Potent%20and%20Selective%20Negative%20Allosteric%20Modulators%20of%20the%20Metabotropic%20Glutamate%20Receptor%202%20for%20the%20Potential%20Treatment%20of%20Alzheimer%E2%80%99s%20Disease&amp;author=J.%20S.%20Coleman&amp;author=R.%20A.%20Capstick&amp;author=U.%20A.%20Rathnayake&amp;author=L.%20Parr&amp;author=S.%20Chang&amp;volume=19&amp;issue=S21&amp;publication_year=2023&amp;pages=e076916&amp;doi=10.1002/alz.076916&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref50">
<cite>

Goh, G. B.
; 
Siegel, C.
; 
Vishnu, A.
; 
Hodas, N.
; 
Baker, N.
. 
How Much Chemistry Does a Deep Neural
Network Need to Know to Make Accurate Predictions?
Arxiv. 2018,</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Arxiv&amp;title=How%20Much%20Chemistry%20Does%20a%20Deep%20Neural%20Network%20Need%20to%20Know%20to%20Make%20Accurate%20Predictions?&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref51">
<cite>Hahnke V. D., Bolton E. E., Bryant S. H.. PubChem atom environments. J. Cheminf. 2015;7(1):41. doi: 10.1186/s13321-015-0076-4.</cite> [<a href="https://doi.org/10.1186/s13321-015-0076-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4540750/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26300985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cheminf.&amp;title=PubChem%20atom%20environments&amp;author=V.%20D.%20Hahnke&amp;author=E.%20E.%20Bolton&amp;author=S.%20H.%20Bryant&amp;volume=7&amp;issue=1&amp;publication_year=2015&amp;pages=41&amp;pmid=26300985&amp;doi=10.1186/s13321-015-0076-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref52">
<cite>Rablen P. R., Perry-Freer N. A.. How the
Arrangement of Alkyl Substituents Affects the
Stability of Delocalized Carbocations. J. Org.
Chem. 2018;83(7):4024–4033. doi: 10.1021/acs.joc.8b00415.</cite> [<a href="https://doi.org/10.1021/acs.joc.8b00415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29518333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Org.%20Chem.&amp;title=How%20the%20Arrangement%20of%20Alkyl%20Substituents%20Affects%20the%20Stability%20of%20Delocalized%20Carbocations&amp;author=P.%20R.%20Rablen&amp;author=N.%20A.%20Perry-Freer&amp;volume=83&amp;issue=7&amp;publication_year=2018&amp;pages=4024-4033&amp;pmid=29518333&amp;doi=10.1021/acs.joc.8b00415&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref53">
<cite>Gonzalez J. D., Florez E., Romero J., Reyes A., Restrepo A.. Microsolvation
of Mg(2)­(+), Ca(2)­(+): strong influence of formal charges in hydrogen
bond networks. J. Mol. Model. 2013;19(4):1763–1777. doi: 10.1007/s00894-012-1716-5.</cite> [<a href="https://doi.org/10.1007/s00894-012-1716-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23306735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Model.&amp;title=Microsolvation%20of%20Mg(2)%C2%AD(+),%20Ca(2)%C2%AD(+):%20strong%20influence%20of%20formal%20charges%20in%20hydrogen%20bond%20networks&amp;author=J.%20D.%20Gonzalez&amp;author=E.%20Florez&amp;author=J.%20Romero&amp;author=A.%20Reyes&amp;author=A.%20Restrepo&amp;volume=19&amp;issue=4&amp;publication_year=2013&amp;pages=1763-1777&amp;pmid=23306735&amp;doi=10.1007/s00894-012-1716-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref54">
<cite>Wang B., Li S. L., Truhlar D. G.. Modeling the Partial Atomic Charges
in Inorganometallic Molecules and Solids and Charge Redistribution
in Lithium-Ion Cathodes. J. Chem. Theory Comput. 2014;10(12):5640–5650. doi: 10.1021/ct500790p.</cite> [<a href="https://doi.org/10.1021/ct500790p" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26583247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Theory%20Comput.&amp;title=Modeling%20the%20Partial%20Atomic%20Charges%20in%20Inorganometallic%20Molecules%20and%20Solids%20and%20Charge%20Redistribution%20in%20Lithium-Ion%20Cathodes&amp;author=B.%20Wang&amp;author=S.%20L.%20Li&amp;author=D.%20G.%20Truhlar&amp;volume=10&amp;issue=12&amp;publication_year=2014&amp;pages=5640-5650&amp;pmid=26583247&amp;doi=10.1021/ct500790p&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref55">
<cite>Kale S., Herzfeld J.. Natural polarizability
and flexibility via explicit
valency: the case of water. J. Chem. Phys. 2012;136(8):084109. doi: 10.1063/1.3688228.</cite> [<a href="https://doi.org/10.1063/1.3688228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3306436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22380034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Chem.%20Phys.&amp;title=Natural%20polarizability%20and%20flexibility%20via%20explicit%20valency:%20the%20case%20of%20water&amp;author=S.%20Kale&amp;author=J.%20Herzfeld&amp;volume=136&amp;issue=8&amp;publication_year=2012&amp;pages=084109&amp;pmid=22380034&amp;doi=10.1063/1.3688228&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref56">
<cite>Cordero B., Gomez V., Platero-Prats A. E., Reves M., Echeverria J., Cremades E., Barragan F., Alvarez S.. Covalent radii revisited. Dalton Trans. 2008;21:2832–2838. doi: 10.1039/b801115j.</cite> [<a href="https://doi.org/10.1039/b801115j" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18478144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dalton%20Trans.&amp;title=Covalent%20radii%20revisited&amp;author=B.%20Cordero&amp;author=V.%20Gomez&amp;author=A.%20E.%20Platero-Prats&amp;author=M.%20Reves&amp;author=J.%20Echeverria&amp;volume=21&amp;publication_year=2008&amp;pages=2832-2838&amp;pmid=18478144&amp;doi=10.1039/b801115j&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref57">
<cite>Jiang T., Zhang X., Vishwanath S., Mu X., Kanzyuba V., Sokolov D. A., Ptasinska S., Go D. B., Xing H. G., Luo T.. Covalent bonding modulated graphene-metal interfacial thermal transport. Nanoscale. 2016;8(21):10993–11001. doi: 10.1039/C6NR00979D.</cite> [<a href="https://doi.org/10.1039/C6NR00979D" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27174416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=Covalent%20bonding%20modulated%20graphene-metal%20interfacial%20thermal%20transport&amp;author=T.%20Jiang&amp;author=X.%20Zhang&amp;author=S.%20Vishwanath&amp;author=X.%20Mu&amp;author=V.%20Kanzyuba&amp;volume=8&amp;issue=21&amp;publication_year=2016&amp;pages=10993-11001&amp;pmid=27174416&amp;doi=10.1039/C6NR00979D&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref58">
<cite>Lee J. H., Avsar A., Jung J., Tan J. Y., Watanabe K., Taniguchi T., Natarajan S., Eda G., Adam S., Castro Neto A. H., Ozyilmaz B.. Van der Waals force: a dominant factor
for reactivity of graphene. Nano Lett. 2015;15(1):319–325. doi: 10.1021/nl5036012.</cite> [<a href="https://doi.org/10.1021/nl5036012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25493357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nano%20Lett.&amp;title=Van%20der%20Waals%20force:%20a%20dominant%20factor%20for%20reactivity%20of%20graphene&amp;author=J.%20H.%20Lee&amp;author=A.%20Avsar&amp;author=J.%20Jung&amp;author=J.%20Y.%20Tan&amp;author=K.%20Watanabe&amp;volume=15&amp;issue=1&amp;publication_year=2015&amp;pages=319-325&amp;pmid=25493357&amp;doi=10.1021/nl5036012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref59">
<cite>Rodriguez-Reyes J. C., Siler C. G., Liu W., Tkatchenko A., Friend C. M., Madix R. J.. Van der Waals interactions
determine
selectivity in catalysis by metallic gold. J.
Am. Chem. Soc. 2014;136(38):13333–13340. doi: 10.1021/ja506447y.</cite> [<a href="https://doi.org/10.1021/ja506447y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25170677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Chem.%20Soc.&amp;title=Van%20der%20Waals%20interactions%20determine%20selectivity%20in%20catalysis%20by%20metallic%20gold&amp;author=J.%20C.%20Rodriguez-Reyes&amp;author=C.%20G.%20Siler&amp;author=W.%20Liu&amp;author=A.%20Tkatchenko&amp;author=C.%20M.%20Friend&amp;volume=136&amp;issue=38&amp;publication_year=2014&amp;pages=13333-13340&amp;pmid=25170677&amp;doi=10.1021/ja506447y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref60">
<cite>

Nguyen, K.
; 
Nong, H.
; 
Nguyen, V.
; 
Ho, N.
; 
Osher, S.
; 
Nguyen, T.
. 
Revisiting Over-smoothing and
Over-squashing Using
Ollivier-Ricci Curvature 2022. arXiv: 2211.15779 Accessed 01, November 2022.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=arXiv:%202211.15779&amp;title=Revisiting%20Over-smoothing%20and%20Over-squashing%20Using%20Ollivier-Ricci%20Curvature%202022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref61">
<cite>Buterez D., Janet J. P., Kiddle S. J., Oglic D., Lio P.. Transfer learning
with graph neural networks for improved molecular property prediction
in the multi-fidelity setting. Nat. Commun. 2024;15(1):1517. doi: 10.1038/s41467-024-45566-8.</cite> [<a href="https://doi.org/10.1038/s41467-024-45566-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11258334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38409255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Transfer%20learning%20with%20graph%20neural%20networks%20for%20improved%20molecular%20property%20prediction%20in%20the%20multi-fidelity%20setting&amp;author=D.%20Buterez&amp;author=J.%20P.%20Janet&amp;author=S.%20J.%20Kiddle&amp;author=D.%20Oglic&amp;author=P.%20Lio&amp;volume=15&amp;issue=1&amp;publication_year=2024&amp;pages=1517&amp;pmid=38409255&amp;doi=10.1038/s41467-024-45566-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="ref62">
<cite>Rosa L. C. S., Argolo C. O., Nascimento C. M. C., Pimentel A. S.. Identifying Substructures
That Facilitate Compounds to Penetrate the Blood-Brain Barrier via
Passive Transport Using Machine Learning Explainer Models. ACS Chem. Neurosci. 2024;15(11):2144–2159. doi: 10.1021/acschemneuro.3c00840.</cite> [<a href="https://doi.org/10.1021/acschemneuro.3c00840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11157485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38723285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem.%20Neurosci.&amp;title=Identifying%20Substructures%20That%20Facilitate%20Compounds%20to%20Penetrate%20the%20Blood-Brain%20Barrier%20via%20Passive%20Transport%20Using%20Machine%20Learning%20Explainer%20Models&amp;author=L.%20C.%20S.%20Rosa&amp;author=C.%20O.%20Argolo&amp;author=C.%20M.%20C.%20Nascimento&amp;author=A.%20S.%20Pimentel&amp;volume=15&amp;issue=11&amp;publication_year=2024&amp;pages=2144-2159&amp;pmid=38723285&amp;doi=10.1021/acschemneuro.3c00840&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12332587/bin/ao5c02173_si_001.pdf" data-ga-action="click_feat_suppl" class="usa-link">ao5c02173_si_001.pdf</a><sup> (1.6MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data used
for this work are included in the Supporting Information: compiled
data set. The code used to generate the composite models is available
from the GitHub repository: <a href="https://github.com/EzekMathew/MultiFunction-CHEML_GAT" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/EzekMathew/MultiFunction-CHEML_GAT</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from ACS Omega are provided here courtesy of <strong>American Chemical Society</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1021/acsomega.5c02173"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ao5c02173.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332587/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332587/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332587%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332587/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332587/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332587/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40787347/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332587/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40787347/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332587/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332587/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="u5l9P2oGCOWQ1DLRKUTJlTkQzzO9uQMh0xtj21YL3F9G80ZO59Idjba5vYvq7hAJ">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-d9849939.js"></script>
    
    

    </body>
</html>
